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Abstract
Background: To investigate the mechanisms driving regulatory evolution across
tissues, we experimentally mapped promoters, enhancers, and gene expression in
the liver, brain, muscle, and testis from ten diverse mammals.
Results: The regulatory landscape around genes included both tissue-shared and
tissue-specific regulatory regions, where tissue-specific promoters and enhancers
evolved most rapidly. Genomic regions switching between promoters and enhancers
were more common across species, and less common across tissues within a single
species. Long Interspersed Nuclear Elements (LINEs) played recurrent evolutionary
roles: LINE L1s were associated with tissue-specific regulatory regions, whereas more
ancient LINE L2s were associated with tissue-shared regulatory regions and with
those switching between promoter and enhancer signatures across species.
Conclusions: Our analyses of the tissue-specificity and evolutionary stability among
promoters and enhancers reveal how specific LINE families have helped shape the
dynamic mammalian regulome.
Keywords: Regulatory evolution, Gene regulation, Promoters, Enhancers,
Transposable elements, Long Interspersed Nuclear Elements (LINEs), LINE L1, LINE L2,
Mammals
Background
Mammalian tissues are composed of hundreds of cell types, each with its own tissue-
specific gene expression program. These programs are controlled by proximal pro-
moters and distal enhancer regions [1].
Promoters and enhancers are traditionally considered distinct and minimally
overlapping categories, although specific genomic regions can show both promoter
and enhancer activity between cell types of a species [2]. Some promoters show
characteristics of enhancers, such as impacting expression of distal genes [3, 4],
showing chromatin signatures of enhancers [3], or contacting another promoter
[5]. Conversely, some enhancers show characteristics of promoters by driving
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transcription [6–8] or functioning as alternative promoters [9]. Evolutionary studies
on a limited number of lineages and regulatory regions have suggested that a sub-
set of enhancers can be repurposed to promoters across species [10].
While transcriptional divergence has been extensively characterized in mammalian
tissues [11–13], the evolution of the associated regulatory regions is not well under-
stood. Enhancer and promoter evolution has mostly been studied by comparing one
mammalian tissue or cell type across several species [14–17]. This approach is unable
to compare evolutionary trends across tissues. A second approach comparing the regu-
latory landscapes among various tissues of mouse and human [18–21] affords limited
insights into the rate and lineage-specificity of regulatory evolution.
Nevertheless, these studies revealed that enhancers have a high rate of evolutionary
turnover [14, 16–19]. For example, less than 5% of human embryonic stem cell en-
hancers are conserved in mouse [16]. Promoter regions are more evolutionarily stable
[14, 18, 19], although only around half of the transcription start sites are precisely con-
served between mouse and human [21, 22].
Tissue-specific promoter and enhancer evolution in mammals is partly shaped by
transposable elements, which can contribute novel transcription factor binding sites
[23]. To date, most studies have focused on the regulatory contribution of the endogen-
ous retrovirus (ERV) superfamily of the long terminal repeat (LTR) subclass [24–26]
and the short interspersed nuclear element (SINE, sometime represented as Short IN-
terspersed Element) superfamily of the non-LTR subclass [19, 27–29]. Less is known
about regulatory contributions of the long interspersed nuclear element (LINE, some-
times represented as Long INterspersed Element) superfamily, which makes up around
20% of mammalian genomes [30]. Both LINE L1s and L2s evolved before the mamma-
lian radiation, although the L2 family is more ancient [31]. In many mammalian ge-
nomes, L1s are the only elements still actively retrotransposing [32]. L1s are often
transcribed in a cell-type-specific manner [33–36] and there is limited evidence for
their direct contribution to gene regulation [37]. In human cells, LINE L2s are
expressed as miRNAs [38] and may have regulatory activity [29, 39], but it is unknown
whether L2s play a regulatory role in other mammalian lineages.
Here, by comparing the epigenetic and transcriptional landscapes of multiple tissues
and species across nearly 160 million years of mammalian evolution, we revealed new
insight into the molecular mechanisms underlying tissue-specific and tissue-shared
regulatory evolution. Our analyses demonstrated how promoters and enhancers can
interchange regulatory signatures between species and discovered how different LINE
families help shape tissue-specificity and regulatory signatures.
Results
Mapping regulatory evolution across four tissues in ten mammals
The species selected for mapping active regulatory regions represent several mammalian
clades including primates (macaque and marmoset), Glires (mouse, rat, and rabbit), Laur-
asiatheria (pig, horse, cat, and dog), and marsupials (opossum) (Additional file 1: Table
S1); all species have high-quality reference genomes with extensive annotation [40].
We profiled the regulatory landscape of adult liver, muscle, brain, and testis. Samples
taken from these organs represent three somatic tissues originating from distinct
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developmental germ layers and one germline tissue. In each tissue, matched functional
genomics experiments were performed in biological triplicate (with one exception, see
the “Materials and methods” section, Additional file 2: Table S2). Chromatin immuno-
precipitation followed by high-throughput DNA sequencing (ChIP-seq) was used to
map three histone modifications associated with regulatory activity: histone 3 lysine 4
trimethylation (H3K4me3), histone 3 lysine 4 monomethylation (H3K4me1), and his-
tone 3 lysine 27 acetylation (H3K27ac) (Fig. 1a, b; Additional file 1: Figure S1). Libraries
were sequenced to saturation: 20 million reads were sufficient to saturate the signal for
H3K4me3 and H3K27ac across all tissues, while 40 million reads were needed to satur-
ate H3K4me1 signal (Additional file 1: Figures S1 and S2A; Additional file 3: Table S3;
Materials and methods). We called peaks for each replicate with MACS2 and kept
those enriched for each mark based on reported q-value (Materials and methods). All
following analyses used highly reproducible peaks present in at least two biological rep-
licates (Additional file 1: Figures S1 and S2B).
Within each tissue, active promoters were defined as regions enriched for both
H3K4me3 and H3K27ac [41, 42] (Additional file 1: Table S4; Figure S1; Fig. 1a and b).
Active enhancers were defined as regions enriched for both H3K4me1 and H3K27ac,
but not H3K4me3 [41, 43]. Primed enhancers, or intermediate enhancers, were defined
as regions enriched for H3K4me1 only [44, 45]. These are thought to be “primed” with
H3K4me1 and may become readily active in response to specific stimuli [46]. The me-
dian of the H3K27ac peak enrichment is lower for active enhancers than for active pro-
moters although the distributions overlap (Additional file 1: Figure S2C). A similar
trend was observed for H3K4me1 enrichment distributions for active and primed en-
hancers with greater overlap (Additional file 1: Figure S2C).
To quantify genome-wide transcriptional activity, we generated matched total RNA-
seq for the same samples used to map histone modifications (with rare exceptions, see
the “Materials and methods” section, Additional file 2: Table S2). RNA-seq libraries
were generally sequenced to a minimum of 40 million mapped reads for somatic tissues
and 100 million for testis (Additional file 1: Figure S1; Additional file 4: Table S5). We
used these data to improve the publicly released Ensembl genome annotations for eight
species (Materials and methods) [40, 47].
From these nearly 500 matched experiments across four adult tissues and ten mam-
malian species, we annotated more than 2.8 million regulatory regions. This dataset
captured a substantial proportion of known regulatory regions genome-wide and iden-
tified thousands of novel regulatory regions in each tissue (Additional file 1: Figures
S3A, B and C). This dataset provides a comprehensive and consistent resource for
inter-tissue and inter-species analyses of regulatory evolution, especially for species that
have not been extensively studied.
Tissue-level regulatory and transcriptional landscapes are consistent across mammals
The number of regulatory regions identified for each tissue using consensus peaks
(Additional file 1: Figure S1 and Figure S2B) was largely consistent across species (Fig.
1c). Liver and muscle are relatively homogeneous somatic tissues consisting mostly of
hepatocytes and myocytes, respectively. Each of these two tissues expressed approxi-
mately half of all annotated genes (Fig. 1d) and had on average 18,000 active promoters,
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36,000 active enhancers, and 49,000 primed enhancers (Fig. 1c). In the brain, we identi-
fied more active regulatory regions on average: 20,000 active promoters and 41,000 ac-
tive enhancers. This increase is consistent with the higher gene expression we observed
(56% of genes are transcribed), as well as with the greater cellular heterogeneity of brain
Fig. 1 Promoter, enhancer and gene expression mapping demonstrates consistent tissue-level gene
regulation in mammals. a Example conserved, tissue-specific regulatory landscape around Myosin Heavy
Chain 1 and 2 genes (Myh1 and Myh2) in muscle tissue from ten mammalian species. Inset numbers are
maximum read depths for ChIP-seq and RNA-seq, while phylogenetic relationships and species divergences
are shown on the left (see Additional file 1: Figure S1 for experimental workflow). b For the same locus as
in a, regulatory landscapes in the liver, muscle, brain, and testis are shown for mouse and dog. c For each
tissue, the number of biologically reproducible regulatory regions identified is consistent across species.
Within a species, data is shown as stacked bar charts and the cross-species averages are similarly stacked
below the graph. The average number of active promoters (purple), active enhancers (orange), and primed
enhancers (green) across all species is shown below each column. The size of the underlying assemblies in
Gigabases (Gb) is shown for all species. d The fraction of genes (diamonds) and transcripts (triangles)
expressed in each tissue is stable across ten species. The average percentage of expressed genes across all
species is shown as a dotted line with the confidence interval corresponding to +/− one standard
deviation shaded. Species with larger differences between the fraction of expressed genes and transcripts
have more comprehensive annotation
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[48]. Indeed, the number of regulatory regions we identified in whole brain was com-
parable to the combined total found from profiling individual primate brain regions
[49], suggesting that we effectively captured the brain regulome (Materials and
methods). Consistent with previous reports, there were twice as many active enhancers
as active promoters for all three somatic tissues [14, 41].
Testis is distinct from somatic tissues in that it is primarily composed of germ cells
at different stages of spermatogenesis [50]. Testis had more active promoters compared
to other tissues (24,000; Fig. 1c) and expressed the highest portion of annotated genes
and transcripts (69%, Fig. 1d), consistent with known testis transcriptome diversity [50,
51]. Testis also had a lower ratio of enhancers to promoters compared to somatic tis-
sues. Overall, testis regulatory regions were similarly enriched to those in other tissues
(Fig. 1c; Additional file 1: Figures S2A and B) albeit with fewer average H3K4me3 reads
per active promoter because of a larger number of promotors and our decision to use
the same number of reads across tissues (Additional file 1: Figure S4). Additionally, the
H3K27ac enrichment was comparable between the somatic tissues and the testis (Add-
itional file 1: Figure S4). Thus, the distinct regulatory landscape of testis is not the re-
sult of technical differences.
Taken together, we found that promoter and enhancer landscapes correspond to
gene expression, depend on tissue identity, and are consistent across species.
Distinctive regulatory landscapes characterize somatic tissues and testis
Within each species, we analyzed the tissue-specificity (Fig. 2a; Additional file 1: Figure
S6A) of enhancers, promoters, and gene expression and then combined these into an
overview for all species (Fig. 2a). Consistent with previous studies [41, 52], enhancers
were mostly tissue-specific: 76% of active enhancers and 83% of primed enhancers were
found in only one of the four tissues profiled. The largest group of active promoters
were shared across all four tissues (37%; Fig. 2a) and almost half of active promoters
were tissue-specific, split between those that are testis-specific or specific to any of the
three somatic tissues (25% and 23%, respectively). The tissue-specificity of transcripts
mirrored that of active promoters. The numbers of genes and the numbers of tran-
scripts expressed in all four tissues were similar. In contrast, the number of tissue-
specific expressed transcripts was 2–4 times higher than tissue-specific expressed genes,
and more closely matched the number of active promoters (Fig. 2a). This trend is espe-
cially evident in mouse, where the annotation is most comprehensive (Additional file 1:
Figure S6A). This suggests that tissue-specific promoters modulate alternative tran-
script usage.
We investigated the association between promoters and enhancers by assigning en-
hancers to the nearest promoter within 1Mb, in line with studies that have shown that
a substantial majority of enhancers act on the nearest gene [53, 54] (Materials and
methods). We examined ratios of the number of tissue-specific and tissue-shared en-
hancers for each active promoter. Tissue-shared active promoters typically associated
with both tissue-shared enhancers and a larger number of tissue-specific enhancers
(Fig. 2b, left), reflecting the overall tissue-specificity of enhancers (Fig. 2a). In contrast,
tissue-specific active promoters associated with fewer tissue-shared enhancers and
more tissue-specific active enhancers (Fig. 2b, right), compared to tissue-shared
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promoters. Both active and primed enhancers showed similar, and statistically signifi-
cant, trends (Additional file 1: Figure S6B, p value < 2.2e−16). In testis, tissue-specific
promoters associated with fewer tissue-specific active enhancers than did tissue-specific
promoters in somatic tissues (Fig. 2b), reflecting the overall fewer active enhancers ac-
tive in testis (Figs. 1c, 2a).
We assigned regulatory regions to their nearest gene and compared gene expression
levels across tissues using liver as a reference (Fig. 2c). Genes near tissue-shared
Fig. 2 Tissue-specific enhancers are associated with tissue-specific and tissue-shared promoters. a Within each
species, promoter activity and gene expression were distributed between tissue-specific and tissue-shared, while
enhancer activity was mostly tissue-specific (see Additional file 1: Figure S5). The bars are a summation of numbers
across all ten study species while and the pie charts show the portions of tissue-shared (across any two tissues)
and tissue-specific regions split by testis-specific and somatic-specific; mouse as a representative species is shown
in Additional file 1: Figure S6A. b Numbers of tissue-shared (y-axis) and tissue-specific (x-axis) enhancers associated
with each active promoter are shown for the four tissues. The schematic (right) represents two extreme examples:
promoters predominantly associated with tissue-shared enhancers (top) or tissue-specific enhancers (bottom).
Tissue-shared promoters (left panels) are associated with a higher ratio of tissue-shared versus tissue-specific
enhancers; whereas tissue-specific promoters (right panels) are predominantly associated with tissue-specific
enhancers. A linear regression was fitted to the ratio of tissue-specific to tissue-shared enhancers per promoter and
is shown as a line. For a distribution of all the tissue-specific to tissue-shared ratios see Additional file 1: Figure S6B.
c Observed expression changes between tissues for genes associated with regulatory regions in muscle, brain, and
testis. The plots show the distribution of differential expression with liver as a reference (DESeq2 adjusted p value
< 0.05), of genes nearest to 4-tissue-shared regulatory regions and tissue-specific regulatory regions (p values
calculated using one sided Wilcoxon test; tissue-specific expression change is greater than tissue-shared)
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regulatory regions showed similar expression levels across somatic tissues. In contrast,
genes near muscle- and brain-specific regulatory regions had significantly higher ex-
pression in those tissues than in liver (p values < 1.1e−9). This effect was strongest for
promoters and is evident for enhancers (Fig. 2c). For testis, genes associated with
tissue-shared regulatory regions are more highly expressed than in liver (Fig. 2c). Add-
itionally, genes associated with testis-specific regulatory regions are significantly more
expressed in testis than genes associated with tissue-shared regulatory regions (p values <
2.1e−15).
These results demonstrate that regulatory landscapes differ between somatic tissues
and testis and that the number of tissue-specific active promoters corresponds to the
number of genes with tissue-specific expression.
Tissue-shared promoters and enhancers display enhanced evolutionary stability
The association between tissue specificity and evolutionary stability of enhancers and
promoters has remained largely unexplored. Previous work in single tissues demon-
strated that few enhancers are conserved across mammals [14, 41], and those conserved
are more likely to be active in multiple cellular contexts [55]. Here, we exploited
matched enhancer and promoter landscapes to identify evolutionarily maintained and
recently evolved regulatory regions (Fig. 3a; Additional file 1: Figure S5; Materials and
methods). Across all ten species, we found 1.6 million recently evolved regulatory re-
gions and 1.2 million maintained regulatory regions. Most tissue-shared regulatory re-
gions (76%) were maintained in evolution across two or more study species, although
there were also many tissue-shared regions that were recently evolved. In contrast,
most tissue-specific regulatory regions were recently evolved (89%; Fig. 3a).
We quantified evolutionary rates for tissue-shared and tissue-specific regulatory re-
gions. Through pairwise comparisons of alignable regions, we calculated the fraction of
promoters and enhancers maintained between each pair of species, and then used the
slope of a linear fit to estimate the evolutionary rate of change (Fig. 3b, Materials and
methods). Studies in single mammalian tissues have found that enhancers evolve more
rapidly than promoters, but without differentiating between active and primed en-
hancers [14, 18]. We demonstrate that primed enhancers evolve much faster than ac-
tive enhancers for both tissue-shared and tissue-specific regulatory elements.
More importantly, we consistently found that tissue-specific regulatory regions
evolved more rapidly than their tissue-shared counterparts (Fig. 3b, p value < 0.021).
This result is unaffected by enrichment of the histone modifications used to define the
regions (Additional file 1: Figure S7A). Interestingly, tissue-specific active promoters
evolved at rates comparable to enhancers, which may partly explain previous observa-
tions of fast rates of transcription start site evolution [19, 22].
We then asked whether regulatory regions evolve faster in particular tissues (Fig. 3c).
Among promoters, those with testis-specific activity evolved most quickly, followed by
liver-specific ones. In contrast, among both active and primed enhancers, those with
liver-specific activity were the fastest evolving. Brain-specific regulatory regions evolved
the most slowly (Fig. 3c). These tissue-specific rates of regulatory evolution give new
insight into previously reported gene expression evolution rates, which found relatively
small changes in brain and accelerated evolution in testis and liver [11, 12]. Our results
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suggest that both enhancers and promoters underlie the previously observed evolution-
ary rates of gene expression across tissues.
In sum, tissue-shared regulatory activity is a trait predictive of slower evolutionary
turnover, regardless of the class of regulatory region or tissue of activity.
Regions that switch promoter and enhancer signatures within a species are uncommon
and are not evolutionarily maintained
Some genomic regions can act as either promoters or enhancers in different contexts
[4], but the evolutionary turnover and maintenance of such dynamic regulatory re-
gions have not been evaluated. We defined intra-species dynamic regulatory regions as
those with differing histone modification signatures across tissues within a single spe-
cies (Additional file 1: Figure S5; Fig. 4a; Materials and methods). Regions identified as
active promoters in one tissue and active and/or primed enhancers in another tissue
were defined as intra-species dynamic promoter/enhancers (dynamic P/Es). Similarly,
Fig. 3 Tissue-specific regulatory regions have higher evolutionary turnover than tissue-shared regions. a The
number of tissue-shared and tissue-specific regulatory regions that are either maintained or recently
evolved across all ten species (see Additional file 1: Figure S5). The majority of tissue-shared regulatory
regions are maintained across species: 73% of active promoters, 80% of active enhancers, and 75% of
primed enhancers. The majority of tissue-specific regions are recently evolved, although 11% of active
promoters, 12% of active enhancers and 10% of primed enhancers are maintained. b Evolutionary rates of
alignable tissue-shared and tissue-specific regulatory regions estimated by linear regression of activity
maintenance between all pairs of species and zero points estimated from interindividual variation (Materials
and methods). For tissue-shared regions, the slope of the regression line for active promoters is lower than
that of active enhancers or primed enhancers (two-way ANOVA of linear regression: active promoters vs
active enhancers p value 0.0063; active promoters vs primed enhancers p value 0.0056). For all tissue-
specific regions, the rates of evolution are either indistinguishable or greater than that for tissue-specific
primed enhancers (two-way ANOVA of linear regression: active promoters slope vs primed enhancer slope,
p value 0.011; active enhancers slope vs primed enhancers slope, p value 0.021). c Evolutionary rates of
tissue-specific regulatory regions further stratified by tissue of activity. The slope of the regression line for
testis-specific active promoters is significantly higher than for promoters with activity specific to the liver,
muscle, or brain (two-way ANOVA of linear regression: testis-specific active promoters vs all other tissue-
specific active promoters p value 3 × 10−8). However, all tissue-specific promoters evolve more rapidly than
tissue-shared promoters, regardless of their tissue of activity (two-way ANOVA of linear regression: all tissue-
specific active promoters (Fig. 3b) vs tissue-shared active promoters (Fig. 3b) p value 4 × 10−8)
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regions identified as active enhancers in one tissue and primed enhancers in another
were defined as intra-species dynamic enhancers (dynamic Es). Between the four tis-
sues, only a small portion of each species’ regulome was intra-species dynamic on aver-
age: 7% of active promoters, 11% of active enhancers, and 7% of primed enhancers (Fig.
4a).
We compared the evolutionary rates of intra-species dynamic P/Es and dynamic Es
with that of typical promoters and enhancers (Additional file 1: Figure S7B; Materials
and methods). Dynamic P/Es had a higher evolutionary rate than tissue-shared active
promoters or active enhancers and were more maintained than tissue-specific active
promoters or active enhancers. Similarly, dynamic Es had a higher rate than tissue-
shared active enhancers and were more maintained than tissue-specific active en-
hancers or primed enhancers. Thus, the evolutionary stability of dynamic regulatory re-
gions is between that of their tissue-shared and tissue-specific counterparts.
We investigated the evolutionary stability of intra-species dynamic P/Es and dynamic
Es by asking how often they aligned to a similarly dynamic region in another species
(Fig. 4b; Additional file 1: Figure S8B; Materials and methods). The majority of intra-
species dynamic P/E alignments were to non-dynamic regions in other species (73%)
with approximately equal numbers aligning to active promoters, active enhancers, and
primed enhancers. Similarly, most alignments that included intra-species dynamic Es
(80%) were either to active or primed enhancers, with only 12% aligning to another dy-
namic E.
In sum, the dynamic regions that switch promoter and enhancer signatures between
tissues within one species are relatively rare and are not maintained as intra-species dy-
namic regions across species.
Promoter and enhancer signature dynamics are common between species
The functional signatures of regulatory regions may also change across species. Indeed,
prior studies have identified a limited set of genomic regions that switch between pro-
moter and enhancer signatures within primates or rodents [10].
We thus investigated the evolutionary stability of histone modification signatures for
all pairwise comparisons between species where regulatory activity is maintained (Add-
itional file 1: Figure S5; Materials and methods). For example, we asked how often an
active promoter in mouse aligns to an active enhancer in dog—regardless of the tissue
of activity. Active promoters were the most stable regulatory class across evolution: for
those that were maintained as a regulatory region across species, 80% of pairwise com-
parisons were identified as promoters in both species (Fig. 4b). The two classes of en-
hancers were less stable across evolution: only 42% and 60% of pairwise comparisons
involving active and primed enhancers, respectively, retained the same enhancer signa-
ture between the two species.
Similar to the intra-species dynamic regions, we defined evolutionarily dynamic re-
gions as those with different regulatory signatures between species (Additional file 1:
Figure S5). We found that evolutionarily dynamic regions were more common than
intra-species dynamic regions. Specifically, 15% of pairwise comparisons involving pro-
moters were evolutionarily dynamic (Fig. 4b) compared to only 7% intra-species dy-
namic (Fig. 4a). For enhancer comparisons, 44% of active enhancers aligned to a
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Fig. 4 (See legend on next page.)
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primed enhancer in another species (Fig. 4b), compared to 10% of active enhancers in
one species identified as primed enhancers in a different tissue (Fig. 4a). Indeed, almost
half of active enhancers were readily interchangeable with primed enhancers across ten
mammals, suggesting that enhancer states are in an approximate evolutionary balance.
To explore whether histone modification enrichment influences the evolutionary sta-
bility of regulatory signatures, we compared the enrichment of peak calls underlying
evolutionarily dynamic and stable regulatory regions (Additional file 1: Figure S8A; Ma-
terials and methods). Evolutionarily dynamic active promoters are weaker than their
stable counterparts, active enhancers are similar, and primed enhancers are stronger
when evolutionarily dynamic. Thus, ChIP enrichment alone cannot explain evolution-
ary changes between regulatory signatures.
We next limited our evolutionary stability analyses to only those regulatory regions
maintained within the same tissue across evolution (Additional file 1: Figure S8B). For
evolutionary dynamic regions within the same tissue, a comparable number of active
promoters (75–78% of pairwise comparisons; Additional file 1: Figure S8B) are stable
compared to those stable between any tissue (80% of pairwise comparisons; Fig. 4b).
(See figure on previous page.)
Fig. 4 Promoter and enhancer signature is highly dynamic across species, but not within species. a Within
a species, dynamic P/Es (red) were regions identified as an active promoter in one tissue and an enhancer
in another tissue, and dynamic Es (blue) were an active enhancer in one tissue and primed in another.
Numbers for each category are summed across all ten species. Within a species and across tissues, only 4%
of the regulome is composed of intra-species dynamic regions. b Pairwise comparisons between
maintained regulatory regions show how often regulatory signature changes between species. A substantial
proportion of regulatory regions align to a region with a different regulatory signature in another species:
20% of pairwise comparisons with active promoters, 58% with active enhancers and 40% with primed
enhancers are evolutionarily dynamic. Almost half of active enhancers (44%) aligned to primed enhancers.
Dynamic P/Es (red) and dynamic Es (blue) almost always align to non-dynamic categories in other species
(73% and 88% respectively), illustrating the evolutionary instability of this regulatory assignment. An
enlargement of the intra-species dynamic regions is shown on the right for clarity. For changes of
regulatory changes within the same tissue between species see Additional file 1: Figure S8B. c Evolutionary
rates of changing regulatory signatures among maintained regulatory regions estimated by linear
regression of pairwise comparisons. Across evolution, maintained active promoters (crosses) and active
enhancers (diamonds) were more likely to change regulatory signature as evolutionary distance between
species increased. d Evolutionary directionality of dynamic regulatory signatures estimated by outgroup
analysis of mouse/rat/rabbit and cat/dog/horse triads. Gray inset example: in 448 cases when a genomic
region is an active promoter in one ingroup species and an active enhancer in the other, the outgroup
species was most likely to be an active enhancer (46%), and least likely to be an active promoter (20%). The
distributions of outgroup active promoters, active enhancers and primed enhancers for each ingroup
combination is statistically different from the background (All) distribution (chi-square two-tailed test,
***p < 0.001). Outgroup analysis was performed separately for each triad group, and then combined (see
Additional file 1: Figure S8C and D). e Composite model based on the observed likelihood of regulatory
regions changing or maintaining regulatory signatures over evolution. The thickness of the lines reflects the
relative likelihood of evolutionary change, as calculated from the most parsimonious evolutionary
relationships from the triad data in d and normalizing the outgoing lines from each state to one. f
Validation of regulatory signature assignment using the average ChIP-seq read enrichment for evolutionarily
dynamic regulatory regions and equal numbers of randomly selected control regions. Dynamic regions
were the AP/AE ingroup regions identified as AE in the outgroup analysis in d. Total number of regions
used are shown as insets. g Distribution of RNA-seq read counts for evolutionarily dynamic active
promoters (AP) and active enhancers (AE) shown in f, and equal numbers of randomly selected control
active enhancers that are not evolutionarily dynamic (p values calculated using one sided the t-test for
greater expression). h Tissue distribution of evolutionarily dynamic P/Es in the species where they were an
active promoter, active enhancer or primed enhancer. When showing signatures of active promoters (left;
purple), they were less likely to be tissue-shared and more likely to be testis-specific than all promoters
(compared to Fig. 2b). When showing enhancer signatures, they were more likely to be tissue-shared than
all enhancers (Fig. 2b bottom orange and green)
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Enhancers are more stable when only considering evolutionary dynamic regions within
the same tissue: 45–49% of active enhancers and 43–45% of primed enhancers (Add-
itional file 1: Figure S8B) are stable, compared to 42% and 60%, respectively, when con-
sidering changes between any tissue (Fig. 4b). Together, these results demonstrate that
regulatory signature changes do occur within the same tissue across evolution and indi-
cate that enhancers are more dynamic than promoters.
We investigated whether regulatory regions were more likely to change signature
with increasing evolutionary distance. We calculated the proportion of maintained pro-
moters that switch between active promoter and any enhancer (evolutionarily dynamic
P/Es; Additional file 1: Figure S5) as well as the proportion of maintained active en-
hancers that switch between active and primed enhancers (evolutionarily dynamic Es;
Additional file 1: Figure S5). The proportion of maintained active promoters and active
enhancers changing regulatory signature and becoming evolutionarily dynamic in-
creased with greater evolutionary distance (Fig. 4c). The rate of switching between ac-
tive and primed enhancers was higher than between promoters and enhancers (Fig. 4c).
With this, we have quantified two evolutionary trajectories of regulatory regions: the
rate of overall loss of regulatory regions (Fig. 3b) and the frequency at which main-
tained regions change their regulatory signature across species (Fig. 4c).
To examine directionality of changing regulatory signatures, we focused on species in
our phylogeny with shorter evolutionary distances and clear ingroup and outgroup rela-
tionships. We separately investigated mouse and rat with rabbit as outgroup, and cat
and dog with horse as outgroup. For both trios, we considered only regulatory regions
that were maintained across all three species. For each regulatory region, we deter-
mined the regulatory signature in the outgroup species given the signatures in the two
ingroup species, regardless of the tissue of activity (Additional file 1: Figure S5). As ex-
pected, when a genomic region was defined as an active promoter in both ingroup spe-
cies, it was also defined as an active promoter in the outgroup 95% of the time (Fig. 4d;
Additional file 1: Figures S8C and D).
When a genomic region was consistently identified as an active enhancer in both
ingroup species, it was a primed enhancer 46% of the time in the outgroup (Fig. 4d;
Additional file 1: Figures S8C and, D). Correspondingly, when a region was identified
as a primed enhancer in both ingroup species, it was an outgroup active enhancer 25%
of the time. These results further demonstrate that active and primed enhancers are
readily interchangeable throughout evolution. Similarly, when a region was defined as
an active enhancer in one ingroup species and a primed enhancer in the other, it was
identified as an outgroup active enhancer 37% of the time and as a primed enhancer
61% of the time. This suggests that for evolutionarily dynamic Es, the ancestral state is
almost twice as likely to be a primed enhancer than an active enhancer. Thus, primed
enhancers are more likely to evolve into active enhancers than the reverse, yet both
types of changes are widespread.
Promoters often arise from ancestral enhancers
Our data enabled us to quantitatively investigate the suggested model that promoters
arise from ancestral enhancers [10]. Regions identified as an active promoter in one
ingroup species and an active or primed enhancer in the other were identified as an
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enhancer in the outgroup species more than 80% of the time (Fig. 4d; Additional file 1:
Figures S8C and D). The similar contribution of active and primed enhancers in the
outgroup is likely due to their rapid evolutionary interchange. At these evolutionary
distances, promoters arise from enhancers six times more often than enhancers arise
from promoters.
We used the frequency of regulatory signature change observed in the outgroup ana-
lysis to model regulatory signature evolution (Fig. 4e; Materials and methods). Our
model predicts that active promoters are most likely to maintain their signature, and
primed enhancers are about as likely to evolve to active enhancer signatures as they are
to remain primed. Active enhancers have two equally likely evolutionary fates: main-
taining their signature or evolving into primed enhancers.
Finally, we validated the evolutionary switching of regulatory signatures from enhancers
to promoters by examining the enrichment of histone modifications and transcription
around evolutionarily dynamic P/Es identified in the outgroup analysis (Fig. 4e; Additional
file 1: Figures S8C and, D). We used parsimony to select regions that were most likely to
represent evolutionary switches from active enhancer to active promoter (ingroups: active
promoter, active enhancer; outgroup: active enhancer), and compared the ChIP-seq and
RNA-seq read enrichment between regions marked as active promoters and active en-
hancers in the ingroups. The regions showed characteristic chromatin signatures of active
enhancers and active promoters (Fig. 4f). Furthermore, ingroup active promoters had in-
creased transcription of flanking regions compared to ingroup active enhancers (Fig. 4g),
indicating that the regulatory signature change leads to higher transcriptional activity.
Evolutionarily dynamic promoters are more likely to be tissue specific
We initially defined evolutionarily dynamic P/E regions without considering their tissue of
activity (Additional file 1: Figure S5). We examined the tissue-specificity of these regions
and compared it to the overall tissue-specificity pattern for promoters and enhancers (Fig.
2b). For each region, we separately characterized the tissue-specificity in species where it
showed signatures of an active promoter, active enhancer, or primed enhancer (Fig. 4h).
In species where evolutionarily dynamic regions had an enhancer signature, they were
mostly tissue-specific, similar to the trend for all enhancers (Fig. 2b) and were only slightly
more likely to be tissue-shared than all other enhancers (24% evolutionarily dynamic en-
hancers active across more than two tissues, compared to 20% of all enhancers; binomial
test p value < 2.2*10−16). When evolutionarily dynamic regions showed promoter signa-
tures changes to tissue-specificity were more pronounced, with only 16% of them being
active across all four tissues (Fig. 4h) compared to 37% of all promoters (Fig. 2b; binomial
test p value < 2.2*10−16). Interestingly, in the species where evolutionarily dynamic P/Es
had promoter signature, 41% were testis-specific (Fig. 4h), which is significantly higher
than the 25% observed for all promoters (Fig. 2b; binomial test p value < 2.2*10−16). These
results indicate that evolutionarily dynamic promoters change both regulatory signature
and tissue-specificity between species.
LINEs are a versatile source of regulatory activity
We next asked how specific classes of repeat elements contribute to the evolution of
tissue-specific and tissue-shared regulatory activity across mammals. We separately
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analyzed recently evolved and maintained regulatory regions (Fig. 3a) and identified
which transposable elements they overlap. We grouped transposable elements into
LINEs, SINEs, LTRs, and DNA transposons, and then compared the enrichment of an-
notated transposable element families between tissue-specific and tissue-shared regula-
tory regions (Materials and methods). Various families of transposable elements within
the LTR and SINE groups such as Alu, B2, and ERVL elements contributed to tissue-
specific and tissue-shared active promoters in a lineage-specific manner (Fig. 5a; Add-
itional file 5: Table S6), in line with previous observations [26, 27]. These lineage-
specific trends are not due to large differences in assembly completion: 98% of reads
map to the finished quality mouse genome and, on average, 96% of reads to all other
genomes (Additional file 3: Table S3).
Across all study species, we found that tissue-specific active promoters were enriched
with LINE L1 family of transposons as compared to their tissue-shared counterparts
despite regulatory regions not overlapping LINEs more than would be expected by
chance (Additional file 1: Figure S9A). In contrast, tissue-shared active promoters were
enriched in the LINE L2 family (Fig. 5a; Additional file 1: Figure S9A; Additional file 5:
Table S6; Additional file 6: Table S7). This was observed for both recently evolved (Fig.
5a, Additional file 5: Table S6) and evolutionarily maintained (Additional file 1: Figure
S9A; Additional file 6: Table S7) active promoters. The same trend of LINE L1 and L2
enrichment was observed in recently evolved and maintained active enhancers although
the trend is weaker; this trend was not as evident for primed enhancers (Fig. 5a; Add-
itional file 1: Figure S9A; Additional file 5: Table S6; Additional file 6: Table S7). On
average 97% and 96% of quality-controlled reads (Materials and methods) mapped
uniquely within LINE L1s and L2s (Additional file 7: Table S8) respectively, compared
to 99% in non-repetitive genomic regions, indicating that the differences we observe
are not due to mapping efficiency.
To gain insight into the impact of LINEs on transcription, we examined the histone
modification enrichments (Fig. 5b) and gene expression (Fig. 5c) within 10 Kb of active
regulatory regions overlapping LINEs. Recently evolved active promoters that were
tissue-shared and contained L2s (7% of recently evolved promoters) had both high en-
richment of H3K4me3 and H3K27ac and increased nearby transcription. The 9% of the
recently evolved active promoters that were both tissue-specific and contained L1s
showed enrichment only in the relevant tissue.
To assess transposable element contribution to regulatory signature dynamics, we
compared their enrichment in evolutionarily dynamic P/E regions to those regions that
retain stable regulatory signatures between species (Fig. 5e; Additional file 8: Table S9;
Materials and methods). Among active enhancers, evolutionarily dynamic P/Es showed
relative enrichment in the LINE L2 family compared to stable active enhancers. In con-
trast, stable active enhancers were enriched for the LINE L1 family. This trend is also
evident for active promoters and primed enhancers in some lineages.
Genomic characteristics of LINEs associated with regulatory regions
We investigated whether regulatory activity was associated with the evolutionary timing
of LINE retrotransposition. The age of each LINE was estimated by its divergence from
the consensus sequence. LINEs were divided into those that overlap identified
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Fig. 5 (See legend on next page.)
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regulatory regions and those that do not (Fig. 5d; Additional file 1: Figure S10A). As ex-
pected, LINE L2s were older than L1s regardless of regulatory association [31]. For all
study species, the age of LINE L2s was similar for recently evolved tissue-shared regula-
tory regions, evolutionarily dynamic regions, and for L2s not associated with any regu-
latory activity.
LINE L1s that overlapped regulatory regions were significantly more diverged (Fig.
5d; p value < 2e−16) and thus older than those that were not regulatorily active. Specific-
ally, regulatory regions that overlapped L1s were less likely to overlap the youngest L1s.
This effect varied across species and was especially pronounced in rodents, primates,
and opossum, where many L1s arose recently and have remained regulatorily inactive
(Additional file 1: Figure S10A). Using the reported mutation rates of primate LINEs
[56], we estimated that the expansion of L2s happened before the divergence of euther-
ian mammals (~ 100 million years ago), and the L1 expansion after the split, consistent
with previous whole genome findings [57].
We sought evidence of selection in LINEs by examining their genomic characteristics.
First, we compared the length of regulatorily active LINEs to those that were not regu-
latorily active (Additional file 1: Figure S10B). All LINEs, regardless of regulatory activ-
ity, are predominantly truncated forms of the full transposons. However, LINEs
associated with recently evolved regulatory regions tend to be in longer fragments than
regulatorily inactive ones suggesting selectional processes. For promoter-associated
LINEs overlapping known transcription start sites, there is no correlation between
LINE orientation and the direction of transcription (Additional file 1: Figure S10C), in-
dicating that nearby transcription is not likely to be due to the transposable element’s
pre-existing promoter. Next, we compared sequence constraint between tissue-specific
regulatory regions overlapping L1s and L2s and found that both have constrained ele-
ments, but those overlapping L2s are significantly more constrained across their whole
length (Additional file 1: Figure S10D; p value < 2e−16) and contain a larger number of
constrained elements (Additional file 1: Figure S10E; p value < 2e−16). This suggests that
lineage-specific genetic variation unmasks latent regulatory potential in existing LINEs.
(See figure on previous page.)
Fig. 5 Distinct families of repetitive elements contribute to recently evolved and maintained regulatory
regions. a Relative enrichment of recently evolved tissue-shared versus tissue-specific regulatory regions for
selected transposable element families shown as a heatmap. Within each family, significance of tissue-
specific vs. tissue-shared proportions calculated with the z-test and Bonferroni correction (p values ***<
0.001; **< 0.01; *< 0.05; − < 0.1. See Additional file 1: Figure S9B for maintained regions). b Validation of
tissue-specific activity using the average ChIP-seq read enrichment for recently evolved active promoters
associated with LINE L1s and L2s and their flanking regions. c Distribution of RNA-seq read counts for the
promoter flanking regions in b. Dotted lines represent the median of tissue-specific RNA-seq enrichment for
the tissue profiled. P values calculated using one sided the Wilcoxon test; within row test if read counts in
each LINE-associated region type (column) is greater than in all other regions. d Estimated age of LINE L1s
and L2s, as inferred by the number of substitutions from consensus sequence. LINE L1s that overlap
regulatory regions (medium and light gray) are significantly older than inactive L1s (dark gray), while
regulatorily active L2s are of similar age to inactive L2s. Dotted line is the median % divergence of the
corresponding regulatorily inactive LINEs and p values calculated using one sided the Wilcoxon test for
greater sequence divergence. Divergence is shown for all ten species combined; see Additional file 1:
Figure S5B for per-species divergences. e Heatmap of relative enrichment in transposable element families
for regulatory regions with evolutionarily dynamic (switch) versus stable signatures. Within each family,
significance of evolutionarily dynamic vs. stable proportions calculated with the z-test and Bonferroni
correction (p values ***< 0.001; **< 0.01; *< 0.05; − < 0.1)
Roller et al. Genome Biology           (2021) 22:62 Page 16 of 43
Across the mammalian lineage, active regulatory regions consistently associated with
LINE L1 transposable elements if they were tissue-specific, and with LINE L2s if they
were tissue-shared (Fig. 5a; Additional file 1: Figure S9B). LINE L2s also consistently as-
sociated with evolutionarily dynamic regulatory regions (Fig. 5e), which frequently
change both regulatory signature and tissue of activity, suggesting that LINE L2s pro-
vide a more versatile potential for transcriptional regulation than do LINE L1s.
Discussion
Regulatory landscapes are composed of tissue-specific and tissue-shared regions that
appear complex and evolutionarily unstable. We have created a comprehensive experi-
mental dataset characterizing how tissue-specific transcriptional regulation has evolved
from a common mammalian ancestor 159 million years ago. Using four adult primary
tissues from ten species, we identified nearly 3 million regulatory regions and quantified
the associated gene expression. Our analyses have given high-resolution insight into the
evolutionary relationship between tissue-specificity and functional maintenance, char-
acterized changing regulatory signatures across tissues and species, and revealed how
LINE retrotransposons evolutionarily shape tissue-specificity.
Our analyses of the mechanisms of regulatory evolution between species and tissues
have limitations. First, the four tissues we profiled do not represent all possible cell
types, though the distinctive evolutionary mechanisms we have identified are likely ro-
bust, because our categorization of tissue-shared or tissue-specific is unlikely to sub-
stantially change with the addition of more cell types [18]. Second, our analysis does
not capture all enhancers and promoters; like every method to define regulatory re-
gions, it has specific advantages, disadvantages, and biases [2]. We used a widely-
employed approach of combining three histone modification and performed all experi-
ments in at least biological triplicates, yet this strategy cannot identify alternative pro-
moters at high resolution as can techniques like CAGE [21]. Furthermore, H3K4me1,
which differentiates active and primed enhancers, is more variable between replicates than
other histone marks (Additional file 1: Figure S2A). Third, to fully explore how tissue-
specific and tissue-shared regulomes interact to shape the evolution of gene expression
would require the generation of high-resolution, three-dimensional contact data.
Although LINEs do not contribute to regulatory regions more than would be expected
by chance genome wide, we were able to characterize their regulatory roles by comparing
specific regions with each other including tissue-specific to tissue-shared and evolutionar-
ily dynamic to stable. Indeed, we would expect to see greater evolutionary dynamism with
a wider tissue or species sampling and thus a stronger association of LINE L2s with evolu-
tionarily dynamic regions. We were not able to identify known motifs that can account
for the observed differences between LINE L1s and L2s, which may be a consequence of
shared mechanisms of activation for tissue-specific and tissue-shared regulatory regions.
For example, a tissue-specific and tissue-shared promoter in liver, as well as any liver en-
hancer, would require many of the same transcription factors for activation.
Regulatory roles change readily across evolution
Our results reveal that primed and active enhancers are frequently redeployed across
evolution into different regulatory roles. Between tissues within a single species, only a
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small subset of promoters interchange regulatory roles with enhancers, in line with pre-
vious studies [3, 4]. Between species, there was suggestive evidence that ancestral en-
hancers can evolve to promoters in somatic tissues [10]. By analyzing a large number
of species, characterizing a greater diversity of regulatory regions, and including a
germline tissue, we discovered that changing regulatory roles is, in fact, a frequent
event in mammalian evolution. One-fifth of alignments with maintained promoters and
almost half of alignments with enhancers showed evidence of such interchange between
species. The observed frequent evolutionary interchange of active and primed en-
hancers, both between all enhancers and those of comparable enrichment levels, may
be the result of a birth-death balance, or potentially reflect a plasticity in the histone
signatures of enhancers. We demonstrated that enhancers interchange regulatory signa-
tures with promoters across evolution, most frequently with testis promoters. The dis-
tinct regulatory plasticity in testis supports a model wherein germline tissues have
unique roles in evolution [58].
LINE retrotransposons shape regulatory evolution across mammals
One of our most striking results is the opposing contributions of LINE L1s and L2s to
regulatory evolution. Regulatorily active LINEs do not generally arise from lineage-
specific insertions, suggesting that the predominant mechanisms for regulatory activa-
tion—including for those with lineage specific activity—are co-option of ancient ele-
ments. Multiple studies have characterized the contribution of lineage-specific
insertions of transposable elements to regulatory evolution [24, 25, 28, 29]. In contrast,
the regulatory potential of more ancient insertions of transposable elements has been
less studied [27, 59]. LINE L1s are transcribed in a cell-type-specific manner [35],
which corresponds to our findings that L1s are associated with tissue-specific regula-
tory activity. LINE L2s have been less studied, though recently shown to be ubiqui-
tously expressed as miRNAs [38] and to have promoter and enhancer activity in
human tissues [29].
Our data showed that LINEs—both L2s and L1s—are widely used across mammals as
an evolutionary substrate for new promoter and enhancer regulatory activity. LINE L2s
are associated with tissue-shared regulatory activity and evolutionarily dynamic pro-
moter/enhancers. LINE L1s, in contrast, are associated with tissue-specific regulatory
regions, as well as those with stable regulatory signatures that do not switch between
promoter and enhancer regulatory signatures.
Conclusions
By mapping the dynamic mammalian regulome across ten species, we reveal the com-
plex, evolutionarily unstable regulatory landscapes underpinning stable tissue pheno-
types and a role for ancient mammalian repeats in shaping their plasticity.
Materials and methods
The published article includes all code generated or analyzed during this study in stan-
dalone ZIP file Additional file 9: Data S1.
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Species details
The ten species used in this study were rhesus macaque (Macaca mulatta), common
marmoset (Callithrix jacchus), mouse (C57BL/6 J, Mus musculus), rat (Brown Norway,
Rattus norvegicus), rabbit (Oryctolagus cuniculus), cat (Felis catus), dog (Beagle, Canis
familiaris), horse (Welsh Mountain Pony, Equus ferus), pig (domestic pig, Sus scrofa),
and gray short-tailed opossum (Monodelphis domestica). All individuals used in this
study were adults with no known health issues. Wherever possible, tissues from young
adult males were used; however, some tissues were from females or older individuals.
An overview of the origin, sex, and age for each animal used in the study is given in
Additional file 1: Table S1. The details for each individual animal and tissue are given
in Additional file 2: Table S2.
The use of all animals in this study was approved by the Animal Welfare and Ethics
Review Board, under reference number NRWF-DO-02vs, and followed the Cancer Re-
search UK Cambridge Institute guidelines for the use of animals in experimental stud-
ies. Tissues from seven species (macaque, marmoset, rabbit, cat, dog, horse, and
opossum) were excess from routine euthanasia procedures (e.g., from individuals sacri-
ficed during maintenance of research or breeding colonies). Tissues from three species
(mouse, rat, and pig) were purchased commercially (e.g., from animal research supply
companies.)
Source and details of tissues
We performed ChIP-seq and RNA-seq on primary tissues isolated from 10 mammalian
species. Primary tissues used were derived from the liver, skeletal muscle (from the
upper hind leg), brain (whole), and testis. Brain samples were representative of the
whole brain (see details below) for most animals, with the exception of macaque, in
which some of the brain regions were not available (see Additional file 2: Table S2). At
least three independent biological replicates from different animals were used, with the
only exception being H3K4me3 from horse testis, in which two of the replicates were
from the same individual (Additional file 2: Table S2). In most cases, matched tissues
from the same individuals were used for all of the three ChIP-seq targets and RNA-seq
(Additional file 2: Table S2).
Tissues were prepared immediately post-mortem, typically within an hour, to
maximize experimental quality. Tissues were processed by extracting the organ, dicing
the tissue to small pieces and mixing it to get a homogeneous mixture as a typical rep-
resentation of the whole tissue, which was particularly important for whole brain sam-
ples. Tissues were either immediately snap-frozen on dry ice or liquid nitrogen for
RNA-seq, or formaldehyde crosslinked (see below) and then frozen on dry ice for
ChIP-seq.
Chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq)
Fresh, diced tissues were cross-linked in 1% formaldehyde in solution A (50 mM
Hepes-KOH pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 20 min at room
temperature, followed by the addition of 2.5M glycine solution to a final concentration
of approximately 250 mM glycine and incubated for a further 10 min at room
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temperature to neutralize the formaldehyde. Samples were washed with cold PBS then
frozen on dry ice and stored at − 80 °C until use.
Tissues were homogenized by either dounce homogenization of thawed tissues in
PBS (for softer tissues from smaller species), or by grinding frozen tissues with a Qia-
gen TissueLyser II and stainless steel grinding jars, keeping the samples frozen by cool-
ing jars in liquid nitrogen (for tissues from larger species or for muscle). After
homogenization, samples were stored at − 80 °C until use.
Chromatin immunoprecipitations were done in Nunc deepwell (1ml) 96-well plates.
Each plate was set up to contain chromatin from 24 different tissue samples—each split
into three different ChIP reactions (H3K4me3, H3K4me1, and H3K27ac) plus input—for
a total of 96 samples (72 ChIP reactions plus 24 inputs) per plate. As a result, all three
ChIPs from the same tissue sample used the same input, except in cases where one of the
ChIPs failed and needed to be repeated, in which case a new input was used for the new
chromatin prep. Tissue samples were assigned to 96-well plates semi-randomly, while
maintaining a fairly even representation of species and tissue-type per plate. Sample pos-
ition on the plates was distributed in a semi-random fashion, while maximizing the distri-
bution of samples with respect to species and tissue-type across the plate.
Antibodies used were H3K4me3 (Millipore 05-1339), H3K27ac (Abcam ab4729), and
H3K4me1 (Abcam ab8895). Briefly, for each sample, 5 μg antibodies were pre-bound to
25 μL Protein G Dynabeads (Invitrogen) [60]. Sufficient Dynabeads and antibodies of
the same type were pooled for all 24 tissue samples and incubated in 10 mL of block
solution (1.5% BSA w/v in PBS) for at least 6 h at 4 °C. Immediately prior to setting up
the ChIP reactions, after chromatin extracts were prepared (see below), the antibody-
bound beads were washed with 3 × 10mL block solution using a magnetic stand.
Antibody-bound beads were then resuspended in block solution sufficient for 100 μL
per sample and kept on ice.
Twenty-four samples at a time were lysed according to published protocols [60] to
solubilize DNA-protein complexes. Typically 0.3 to 0.5 g of homogenized tissue was
lysed and resuspended in a final volume of 3 mL prior to sonication. Homogenized tis-
sue was resuspended in 10 mL of lysis buffer 1 (50 mM Hepes-KOH pH 7.5, 140 mM
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100) and incubated with
rotation for 10 min at 4 °C. Samples were centrifuged at 2500g for 3 min at 4 °C, and su-
pernatants were discarded. The pelleted tissue was then resuspended in 10mL of lysis
buffer 2 (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) and in-
cubated with rotation for 5 min at 4 °C. Samples were centrifuged at 2500 g for 3 min at
4 °C, and supernatants were discarded. Pelleted tissue was then resuspended in 3 mL
lysis buffer 3 (10 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
0.1% Na-Deoxycholate, 0.5% N-laurolsarcosine), transferred to a 5-mL Eppendorf tube,
and incubated for at least 5 min (or up to 1 h) prior to sonication. Protease inhibitors
(Complete, EDTA-free, Roche, #11873580001) were added to all lysis buffers immedi-
ately prior to use.
Chromatin was fragmented to 300 bp average size by sonication on a Qsonica Q500
with a 1/16″ microtip at 40% amplitude for a total sonication time of 6 min (12 cycles
of 30 s on, 60 s off). After sonication, 10% Triton X-100 was added to each sample to
bring the total concentration of Triton X-100 to 1%. Samples were spun at 16,000 g for
10 min at 4 °C, and the pellet was discarded.
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Each chromatin extract was evenly split to perform three ChIP reactions: H3K4me3,
H3K27ac, and H3K4me1. A small amount of extract (> 3 μL) was reserved and stored
at 4 °C as input chromatin (see below). Chromatin (800 μL per well, corresponding to
approximately 0.1 g of homogenized tissue) and antibody-bound-beads (100 μL of sus-
pension, equivalent to 5 μg of antibody, per well) were loaded into a 96-well Nunc
deepwell 1 mL plate, and incubated overnight at 4 °C with end-over-end rotation.
Washes and subsequent steps were carried out with an Agilent Bravo liquid handling
robot according to published protocols [61]. Briefly, supernatant was discarded, and
magnetic beads were washed 10x with 180 μL cold RIPA solution (50 mM Hepes-KOH
pH 7.6, 500 mM LiCl, 1 mM EDTA, 1% NP-40, 0.7% Na-Deoxycholate), and then 2x
with TBS. Magnetic beads were resuspended in 50 μL of elution buffer (50 mM Tris-
HCl pH 8.0, 10 mM EDTA, 2% SDS) and incubated at 55 °C for 5 h in a thermocycler
to reverse crosslinks and elute from beads. Supernatants were removed from beads, di-
luted with equal volumes of TE buffer, and treated with RNase A (1 μL, Ambion
#2271), followed by Proteinase K (1 μL, Invitrogen). Alongside the ChIP samples, 3 μL
of chromatin input extract (pre-ChIP) was added to elution buffer for the input samples
and was reversed crosslinked, RNase and Proteinase K treated, and purified. Ampure
bead purification was performed on the robot with a 1:1.8 DNA to Ampure bead ratio,
and DNA was eluted in 20 μL elution buffer. DNA concentration was measured with
the Quant-iT dsDNA high-sensitivity kit on the PHERAstar microplate reader and was
subsequently diluted to a concentration of 1 ng/μL.
Illumina sequencing libraries were prepared from ChIP-enriched DNA or input
DNA, using the ThruPLEX kit with 96 dual index adapters (Rubicon Genomics
R400407) on a liquid-handling robot. Sequencing libraries were generally prepared
from 10 ng (10 μL) of DNA; however, the amount of DNA ranged from 0.5 to 15
ng. Most libraries were amplified with 7 or 8 PCR cycles, but those with lower in-
puts of DNA into the library preparation were amplified with up to 16 PCR cycles.
Libraries were run on an Agilent Tapestation 4200 with D1000 tapes for quantifi-
cation. Libraries from each 96-well plate were mixed in equimolar concentrations
into a single pool and sequenced on the Illumina HiSeq4000 with single end 50
base pair reads.
Total RNA sequencing (RNA-seq)
Total RNA was extracted from approximately 25 mg of snap-frozen tissue per sample.
Tissue was thawed into 700 μL TRIzol and homogenized using a Precellys 24 tissue
homogenizer with cooling system and 2mL grinding tubes with beads (soft-tissue kit
CK14 for liver, brain and testis, or the hard-tissue grinding kit MK28-R for muscle) for
two intervals of 30 s. RNA was purified with phenol:chloroform extraction followed by
isopropanol precipitation. RNA concentration was measured on the NanoDrop, sam-
ples were diluted, and 1–10 μg of RNA was taken forward in the procedure. RNA was
treated with the TURBO DNA-free kit (Invitrogen) to remove any residual DNA. Illu-
mina sequencing libraries were prepared using the Illumina TruSeq Stranded Total
RNA with Ribo Gold kit (20020598) with Illumina RNA UD Indexes (20020492) ac-
cording to the manufacturer’s protocol. Samples were run on Agilent Tapestation
D1000 tapes to quantify sequencing libraries. Up to 12 libraries were combined into a
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single pool and sequenced on the Illumina NovaSeq 6000 to generate paired-end 150
base pair reads.
Genome resources
The genome versions used in this study can be found in Additional file 1: Table S1. All
genomes were downloaded from the Ensembl version 98 [40] ftp as unmasked genomic
DNA sequences, to facilitate the discovery of repetitive and transposable elements. For
mouse, we used the primary assembly file, which excludes haplotypes and patches. All
other species had no haplotype or patches, so we used the top-level DNA files.
ChIP-seq mapping (Figures S1 and S2)
Reads were mapped to each species’ genome with BWA-MEM version 0.7.12 [62] using
the default parameters, including the option to discard any alignment that has more
than 10 thousand exact matches in the genome (−c 10,000). For all reads mapping to
less than 10 thousand locations, the location with the highest mapping score was re-
ported by BWA-MEM, or, in the case of multiple locations with the same score, a ran-
domly selected location. Therefore, all reads with an exact repeat in 9999 other
genomic locations would not have been used for downstream analyses, while reads with
a smaller number of exact repeats might have been misplaced in the genome. Low-
quality mapping reads were filtered out using SAMtools view version 1.3 with the -q1
flag [63]. Duplicates were removed with the Picard Tools MarkDuplicates program ver-
sion 2.8.3 (https://broadinstitute.github.io/picard/). Mapping statistics were calculated
using SAMtools flagstat version 1.3. To estimate the signal-to-noise ratio, we checked
that the relative strand correlation (RSC) was above 0.8 for all libraries using Phantom-
peakqual tools version 1.14 [64]. The mapping and RSC results are available in Add-
itional file 3: Table S3.
ChIP-seq peak calling and signal saturation (Figures S1, S2A and B)
To ensure that we saturated the ChIP-seq signal for all libraries, we performed signal
saturation tests (Additional file 1: Figure S2A). With SAMtools view version 1.3, we
subsampled quality filtered and duplicate removed reads from each biological replicate
starting from 5 million reads to the maximum library depth, or to a maximum of 60
million reads, with a step of 5 million. For each subsampled set, we called enriched
ChIP-seq regions using MACS2 version 2.1.1 [65] using the broad peak mode (options:
-q 0.05 --broad --broad-cutoff 0.1). An input library from the same individual and tis-
sue (Additional file 3: Table S3) and subsampled to the same sequencing depth was also
used with MACS2. To discover biologically reproducible peaks, we looked for ChIP-seq
peaks within replicates that overlapped by 50% of their length with at least 50% of the
peak of another replicate. Reproducible peaks appearing in at least two biological repli-
cates were merged to produce the biologically reproducible set of histone enrichment
peaks, while those not overlapping another replicate were not used for further analyses.
The numbers of peaks per replicate and those peaks that are reproducible in at least
two replicates are shown in Additional file 1: Figure S2B. Biologically reproducible
H3K4me3 and H3K27ac reached ChIP-seq saturation at 20 million reads, while
H3K4me1 reached saturation at 40 million reads (Additional file 1: Figure S2A).
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We used the ChIP-seq libraries for H3K27ac and H3K4me3 subsampled to 20 million
reads for all further analyses. Twelve of the somatic H3K4me3 libraries and one testis
H3K4me3 library had less than 20 million reads after quality control and duplicate re-
moval (Additional file 3: Table S3), so we used all the reads from these libraries instead
of subsamples. This did not reduce the total H3K4me3 peak numbers because
H3K4me3 saturates at a sequencing depth well below 20 million reads, especially in the
somatic tissues (Additional file 1: Figure S2A). We subsampled all the H3K4me1 and
matched input libraries to 40 million reads. The matched input sample for the macaque
muscle library (unique identifier do17779) had around 21 million reads, which were
used in MACS2 with the H3K4me1 library do17771.
Capturing the signal across brain regions
To ensure that we are capturing the full complexity of the regulatory landscape in the
brain, we compared our macaque H3K27ac ChIP-seq to a published study across three
brain regions: cerebellum, cortex, and subcortical structures [49]. Across these three
brain regions, Vermunt et al. identified a total of 61,795 H3K27ac peaks in the macaque
genome version rheMac3 while we found 85,025 H3K27ac peaks in whole macaque
brain using genome version Mmul_10, suggesting that we effectively captured the brain
regulatory landscape.
Definitions of regulatory regions (Fig. 1c and Table S4)
Within each species and tissue, we defined regulatory regions from the overlap of bio-
logically reproducible ChIP-seq peak calling and signal saturation (Figures S1, S2A and
B). H3K27ac enrichment is characteristic of active regulatory elements [52, 66, 67].
Concurrent H3K4me3 enrichment [42, 68–70] in active regulatory region is character-
istic of promoters, while concurrent H3K4me1 enrichment [43, 52, 71] is characteristic
of enhancers. We defined:
Active promoters as H3K4me3 enriched regions that overlapped a H3K27ac enriched
region with at least 50% of their length, regardless of whether H3K4me1 enrichment is
also present. We took the length of the H3K4me3 peaks as the final active promoter re-
gion, but excluded the entire joint length of H3K27ac and H3K4me3 from further regu-
latory region calls.
Active enhancers as H3K27ac histone enriched regions that overlap a H3K4me1 re-
gion with at least 50% of their lengths, keeping only the span of H3K27ac peaks as the
final active enhancer region. We excluded the whole region marked with H3K27ac and
H3K4me1 from further regulatory region calls.
Primed enhancers as H3K4me1 enriched regions that have no overlap with H3K27ac
or H3K4me3 enriched regions.
Reannotation of genomes (Fig. 1d)
For mouse and rat, we downloaded the available gene annotations from Ensembl ver-
sion 98 [40]. For all other species (macaque, marmoset, rabbit, pig, cat, dog, horse, and
opossum) we used a combination of our own RNA-seq data (Total RNA sequencing
(RNA-seq)) and publicly available data to reannotate the genomes.
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Transcript model generation
We generated gene annotations for each genome assembly using the previously de-
scribed Ensembl annotation system [47]. Briefly, we generated transcript models from
multiple evidence sources taken from the public archives, using a variety of approaches:
(1) mapping publicly available short-read RNA-seq data from various tissues (search
parameters: paired-end, ≥ 75 bp reads), including data generated by this study (ArrayEx-
press identifiers: E-MTAB-8122, E-MTAB-8118); (2) alignment of species-specific
cDNAs (source: www.ebi.ac.uk/ena obtained March 2019) to the genome; and (3)
protein-to-genome alignments of vertebrate UniProt (UniProt Consortium 2018) pro-
teins with experimental evidence at protein and transcript levels. In addition, whole
genome alignments against human GRCh38.p13 genome assembly were generated
using LastZ [72] to identify regions of conserved synteny that subsequently guided
mapping of conserved CDS exons from the GENCODE human gene set [73]. For pig
and macaque, we mapped publicly available long-read transcriptome data
(PRJNA351265 and PRJNA320013, respectively) to the genome using Minimap2 [74].
Transcript filtering and prioritization
For each locus, low-quality transcript models with suboptimal mapping, limited intron-
defining short read support or non-canonical splice sites were removed before collaps-
ing and clustering non-redundant transcripts into gene models. We prioritized models
generated from transcriptome data, having strong intron supporting evidence and high
sequence identity (> 90% coverage) to known vertebrate proteins. Gap filling was per-
formed using homology data from projections to human annotations and mappings to
UniProt proteins. To distinguish putative transcript isoforms from fragments, we
assessed the coverage of protein alignments to each transcript relative to the size of the
longest predicted open reading frame. Transcriptome data and cDNA alignments were
used to extend models generated using homology data to annotate untranslated regions
(UTR).
Gene model classification
We classified gene models into 3 main types: protein-coding, pseudogene, and long
non-coding RNA (lncRNA) using alignment qualities of all supporting data for each
model. Models with alignments to known proteins, having little or no overlaps with re-
peat regions of the genome, having high intron support and well-characterized canon-
ical splice junctions were classified as protein-coding. Pseudogenes were annotated by
identifying genes with alignments to known proteins but with evidence of frame-
shifting or located in repeat regions of the genome. Single-exon models with a corre-
sponding multi-exon copy elsewhere in the genome were classified as processed pseu-
dogenes. Gene models generated using transcriptomic data (short and long reads),
lacking any protein supporting evidence and did not overlap a protein-coding locus
were classified as lncRNA.
Small non-coding RNA identification: Small non-coding (sncRNA) genes were added
using annotations taken from RFAM [75] and miRbase [76]. BLAST [77] was run for
these sequences to identify homologs in the genome sequence and models were evalu-
ated for expected stem-loop structures using RNAfold [78]. Additional machine
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learning-based filters were applied to exclude predictions with sub-optimal alignments
to the genome and non-conforming secondary structures. For other sncRNAs, models
were built using the Infernal software suite [79].
RNA-seq mapping and normalization (Fig. 1d and Table S5)
The RNA-seq reads were trimmed from adapters and for low-quality bases using Trim-
momatic version 0.33 [80], using the included TrueSeq3 paired-end adapter sequences.
To remove low-quality sequences from the reads, we removed those bases that had an
average quality lower than 15 in a sliding window of four bases and the first and/or last
three bases if below that threshold (options LEADING:3 TRAILING:3 SLIDINGW
INDOW:4:15 MINLEN:36). We only kept reads with a minimum length of 36 bases,
and only those that retained their paired read after trimming.
We mapped the trimmed RNA-seq reads using STAR version 2.6.0a [81], the
Ensembl 98 version of the genomes (Genome resources, Additional file 1: Table S1),
and gene annotation builds (Reannotation of genomes (Fig. 1d)) to map each replicate
RNA-seq library to known genes and transcripts. For STAR mapping, we used the fol-
lowing options:
--outFilterType BySJout --outFilterMultimapNmax 100 --winAnchorMultimapNmax
100 --alignSJoverhangMin 8 --alignSJDBoverhangMin 1 --outFilterMismatchNmax 999
--outFilterMismatchNoverReadLmax 0.04 --alignIntronMin 20 --alignIntronMax
1000000 --quantMode GeneCounts --outSAMtype BAM SortedByCoordinate --out-
SAMstrandField intronMotif.
To normalize the RNA-seq mapped libraries across replicates and tissues of the same
species, we used Cufflinks version 2.2.1 [82]. We used the Cuffquant command specify-
ing the strandedness of the library (option --library-type=fr-firststrand), followed by the
Cuffnorm program treating each tissue as a sample, and each biological replicate as a
replicate for that tissue. This produced normalized expression values for each anno-
tated gene and transcript within a species and across all tissues. In Fig. 1d, a gene or
transcript was considered expressed in a tissue if this normalized value was above 0
FPKM.
Enrichment of called regulatory regions (Figures S2C, S4 and S8)
To investigate the enrichment of peak calls underlying regulatory region calls, we com-
pared their q-values as reported by MACS2 (ChIP-seq peak calling and signal satur-
ation (Figures S1, S2A and B)). Specifically, for each regulatory region, we computed
the average q value across all replicates’ peaks for each histone mark separately using
the average function in bedtools merge -o mean function. To create a set that is com-
parable between regulatory regions we selected for comparisons on the ChIP marks
which the regions share. For active promoters and active enhancers, we used
H3K27ac—this selected for the strongest active enhancers and weakest active pro-
moters on the mark they share. Similarly, to make the active and primed enhancers
comparable, we used H3K4me1, which selected for the strongest primed enhancers and
weakest active enhancers (Additional file 1: Figure S2C).
To compare the signal-to-input enrichment within peaks, we also used the fold-change
as reported by MACS2 (ChIP-seq peak calling and signal saturation (Figures S1, S2A and
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B). For Additional file 1: Figure S4, we report all the fold-changes of all replicate peaks
called after normalization of libraries to depth reported before and using the same q value
cutoff (ChIP-seq peak calling and signal saturation (Figures S1, S2A and B)).
Validation of called regulatory regions (Figures S3A, B and C)
Mouse regulatory regions identified in the current study were compared to mouse regula-
tory regions annotated in Ensembl version 98 [83] and NCBI RefSeq functional elements
[84] (downloaded September 26, 2017). We asked how many of the active promoters identi-
fied in the current study were annotated as promoters in either the Ensembl or RefSeq data-
base. Given that neither external databases differentiate between enhancer types (i.e., active
and primed enhancers) in an analogous manner to us, we combined primed and active en-
hancers identified in the current study into a single set. We then overlapped these en-
hancers with enhancers identified in either the Ensembl or RefSeq database. Overlap of any
length in the genomic coordinates between a regulatory region identified in the current
study and one annotated in the other database (Ensembl or RefSeq) was interpreted to
mean the regulatory regions were common between the two sets, and lack of overlap was
interpreted as a regulatory region specific to either the current study or to the other data-
base (Ensembl or RefSeq). For simplicity, only regulatory regions mapping to chromosomes
were considered for this analysis (those mapping to scaffolds were not considered). The
resulting analyses are shown in Additional file 1: Figure S3A.
For histone enrichment plots, local installations of deepTools version 3.3.1 [85] and
WiggleTools [86] were used as follows: deepTools bamCompare was first used to subtract
the corresponding input libraries from all quality controlled and duplicate removed (but
not subsampled) ChIP-seq libraries and then WiggleTools mean to calculate the ChIP-seq
enrichment within each mouse tissue as an average across all biological replicates for each
histone mark. To create the heatmaps in Additional file 1: Figure S3C, the resulting aver-
ages of read enrichment from H3K4me3, H3K27ac, and H3K4me1 ChIP-seq libraries
were compared with Ensembl Validated (i.e., overlap of our regions and Ensembl regula-
tory regions) and our novel regulatory mouse regions using the deepTools computeMatrix
program with the options scale-regions --beforeRegionStartLength 2000 --afterRegion-
StartLength 2000 --missingDataAsZero --regionBodyLength 2000 --skipZeros and then
plotted with the deepTools plotHeatmap program.
Generating genome browser tracks (Figs. 1a and b)
A biological replicate from a single individual for each species and tissue was arbitrarily
chosen to display in the genome browser. Files were visualized in the IGV genome
browser [87] with the appropriate genome and gene annotations files for each species.
The genomic region around the genes encoding myosin heavy chains 1 and 2 (Myh1
and Myh2) were extracted for each species and tissue from either bedGraph files (for
ChIP-seq data), which represent read pileups for that biological replicate as generated
by MACS2 (ChIP-seq peak calling and signal saturation (Figures S1, S2A and B)) or
wig files of uniquely mapping reads from the STAR alignments for the RNA-seq data
(RNA-seq mapping and normalization (Fig. 1d and Table S5)). Bedgraph files were con-
verted to the TDF file format with IGV tools to aid visualization in the browser. RNA-
seq data are stranded; however, the signal from the coding strand greatly dominated
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over the non-coding strand, and therefore, only the coding strand was shown. Muscle
samples visualized in Fig. 1a were do17377 (macaque H3K4me3), do17393 (macaque
H3K27ac), do18035 (macaque H3K4me1), do22674 (macaque RNA), do17664 (marmo-
set H3K4me3), do17690 (marmoset H3K27ac), do17715 (marmoset H3K4me1),
do22678 (marmoset RNA), do15511 (mouse H3K4me3), do15539 (mouse H3K27ac),
do15528 (mouse H3K4me1), do22610 (mouse RNA), do15941 (rat H3K4me3), do15952
(rat H3K27ac), do15918 (rat H3K4me1), do22601 (rat RNA), do17178 (rabbit
H3K4me3), do17199 (rabbit H3K27ac), do17112 (rabbit H3K4me1), do22688 (rabbit
RNA), do17356 (cat H3K4me3), do17365 (cat H3K27ac), do18036 (cat H3K4me1),
do22638 (cat RNA), do17647 (dog H3K4me3), do17694 (dog H3K27ac), do17725 (dog
H3K4me1), do22643 (dog RNA), do15887 (horse H3K4me3), do15926 (horse
H3K27ac), do15954 (horse H3K4me1), do22676 (horse RNA), do17342 (pig H3K4me3),
do16006 (pig H3K27ac), do16028 (pig H3K4me1), do26160 (pig RNA), do14518 (opos-
sum H3K4me3), do14483 (opossum H3K27ac), do14565 (opossum H3K4me1), and
do22663 (opossum RNA) (Additional file 3: Table S3 and Additional file 4: Table S5).
For mouse and dog, the same muscle samples from the same individuals were visual-
ized in Fig. 1b. Brain, liver and testis samples visualized in Fig. 1b were do17085 (mouse
brain H3K4me3), do17013 (mouse brain H3K27ac), do17044 (mouse brain H3K4me1),
do22662 (mouse brain RNA), do15990 (mouse liver H3K4me3), do16031 (mouse liver
H3K27ac), do16016 (mouse liver H3K4me1), do26179 (mouse liver RNA), do17048
(mouse testis H3K4me3), do17010 (mouse testis H3K27ac), do17079 (mouse testis
H3K4me1), do22603 (mouse testis RNA), do17046 (dog brain H3K4me3), do17056
(dog brain H3K27ac), do17100 (dog brain H3K4me1), do22652 (dog brain RNA),
do17397 (dog liver H3K4me3), do17324 (dog liver H3K27ac), do17341 (dog liver
H3K4me1), do22650 (dog liver RNA), do17392 (dog testis H3K4me3), do17345 (dog
testis H3K27ac), do17327 (dog testis H3K4me1), and do26151 (dog testis RNA).
Intra-species cross-tissue activity (Fig. 2a, Figures S5 and S6A)
Within each species, we defined the tissue-specificity of regulatory regions by compar-
ing the regulatory calls made within each of the tissues separately (Definitions of regu-
latory regions (Fig. 1c and Table S4)). Two regulatory regions were considered active
across tissues if either overlapped another regulatory region of the same regulatory ac-
tivity with at least 50% of its length. i.e., a tissue-shared active enhancer was considered
tissue-shared only if it overlapped an active enhancer in another tissue (Additional file
1: Figure S5). All other combinations were considered intra-species dynamic (Intra-spe-
cies dynamic regulatory signatures (Fig. 4a and S5)) and not included in any analyses or
figures unless explicitly stated. A gene or transcript was considered expressed in a tis-
sue according to the method outlined in RNA-seq mapping and normalization (Fig. 1d
and Table S5).
Figure 2b shows the sum across all ten species for the intersections between
tissue activity using an UpSetR plot version 1.4.0 [88], while Additional file 1:
Figure S6A shows the data only for mouse. For all further analyses regulatory re-
gions and gene expression were considered tissue-specific if they were only active
in a single tissue and tissue-shared if active in two or more tissues (Additional
file 1: Figure S5).
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Association of enhancers to promoters (Fig. 2b and Figure S6B)
We used a distance rule to associate enhancers to promoters they might regulate, given
that around 70% of enhancers do act on their nearest gene [53, 54]. Within each tissue,
we associated primed and active enhancers called in that tissue to the nearest active
promoter also called in that tissue. If there was no active promoter within 1Mb of the
enhancer, they were not assigned to an active promoter. We next tagged each active
promoter, active and primed enhancer as tissue-specific or tissue-shared using the same
rules as above (Intra-species cross-tissue activity (Fig. 2a, Figures S5 and S6A)) and de-
fined an extra category for promoters—those promoters active across all four tissues
were defined as 4-tissue-shared. In Fig. 2b, we show the distribution of the numbers of
active and primed enhancers associated to tissue-specific and tissue-shared active pro-
moters in each tissue. Promoters with more than 20 associated enhancers of any type
are excluded from the graph, and a regression line representing the ratio of tissue-
specific to tissue-shared enhancers is shown. The data is a summary across all ten study
species.
In Additional file 1: Figure S6B, we show the same data without excluding promoters
with more than 20 associated enhancers. In this graph, we represent the number of
tissue-shared and tissue-specific enhancers as log-transformed ratios, adding a pseudo-
count to avoid dividing by zero.
Associations of regulatory regions to genes and differential gene expression analysis
(Fig. 2c)
For each active promoter within each tissue, we found the closest TSS in the given spe-
cies using the Ensembl gene annotation created for this project (Reannotation of ge-
nomes (Fig. 1d)). The TSS was defined as the start, i.e., most downstream coordinate,
of a gene and that gene associated to a promoter if not further away than 1Mb. Next,
we used the enhancer-promoter association from above (Association of enhancers to
promoters (Fig. 2b and Figure S6B)) to extend each active promoter-associated gene to
apply to that promoters’ enhancers.
We performed differential gene expression analyses between all other tissues and
liver in a pairwise manner using DESeq2 version 1.10.1 [89] with default parameters
and a Benjamini-Hochberg adjusted p value threshold of 0.05 (padj < 0.050000). As in-
put for DESeq2, we used raw read counts produced with the STAR aligner (RNA-seq
mapping and normalization (Fig. 1d and Table S5)). Specifically, for each species, we
tested the differential expression between the muscle, brain, or testis against the liver
and in Fig. 2c report log2fold changes that passed the thresholds. Within each tissue,
we further created a more stringent subset from all tissue-shared regulatory regions
(Intra-species cross-tissue activity (Fig. 2a, Figures S5 and S6A)) to only include those
shared across all four tissues (4-tissue-shared).
Whole genome alignments
For whole genome alignment between the eutherian mammals (macaque, marmoset,
mouse, rat, rabbit, pig, cat, dog, and horse), we used the EPO eutherian mammal align-
ments from Ensembl version 98 [90]. For whole genome alignments between the eu-
therian mammals and opossum, we used the PECAN alignments also from Ensembl
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version 98. We aligned all species to mouse in a pairwise manner, first from all other
species to mouse and then from mouse to all other species. A regulatory region was
considered maintained (PMi; see Eq. 1 and Additional file 1: Figure S5) if it overlapped
another regulatory region of any type with at least one base. A regulatory region was
considered recently evolved (PRi; see Eq. 2 and Additional file 1: Figure S5) if it
was aligned to other species but did not overlap a regulatory region in any of
them, or if it was not aligned to any other species. Any regulatory region aligned
to multiple locations was excluded from further analyses, i.e., only 1-to-1 align-
ments were kept.
Equations demonstrating the computation of cross-species conservation of promoters
are shown in the following sections. The same operations were computed for active
and primed enhancers but are not shown here.
The recently evolved and maintained regulomes across species (Fig. 3a)
PAi ¼ PNi þ PLi þ PMi ð1Þ
PMi ¼ PAi − PNi − PLi ð1:1Þ
PAi—number of all active promoters in species i
PNi—number of active promoters in species i with no alignment to any other species
PLi—number of active promoters in species i with an alignment to any other species,
but no regulatory region aligned in any other species
PMi—number of active promoters in species i with an alignment of at least one base
length to any regulatory region in any other species
PRi ¼ PNi þ PLi ð2Þ
PRi—number of recently evolved active promoters in species i
Figure 3a shows the ∑PMi (Eq. 1.1) and ∑PRi (Eq. 2) across all ten species for active
promoters, and analogous calculation for active and primed enhancers
Pairwise comparisons between species (Figs. 3b and c)
We performed two pairwise comparisons, the first stratifying regulatory regions
by tissue-shared and tissue-specific (Fig. 3b), and the second further stratifying
tissue-specific regulatory regions by their tissue of activity (i.e., liver-specific,
muscle-specific, brain-specific, and testis-specific) (Fig. 3c). The stratification was
limited to the identity of the query regulatory region, but the query region was
considered maintained if it aligned to any regulatory region in the other species
(regardless of tissue-specificity). For example, a liver-specific mouse active pro-
moter was consider maintained and counted as tissue-specific (Fig. 3b) and liver-
specific (Fig. 3c) in all the following cases: (1) if it aligned to a liver-specific ac-
tive promoter, (2) if it aligned to a tissue-shared active promoter, (3) if it aligned
to a muscle-specific active promoter, or (4) if it aligned to active or primed en-
hancers of any tissue-specificity in the other species. For definitions of tissue-
specificity, see the “Materials and methods” section Intra-species cross-tissue ac-
tivity (Fig. 2a, Figures S5 and S6A).
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PMi, j—fraction of alignable active promoters with activity in both species i and j, i.e.
aligned to a regulatory active region, defined as maintained regulatory regions. See also
Eq. 6
PMi→ j—number of active promoters in species i with an alignment of at least one
base length to any regulatory region in species j
PLi→ j—number of active promoters in species i with an alignment of at least one
base length to species j, but not aligned to a regulatory region
To calculate the zero point, we generated a fourth ChIP-seq replicate for all histone
modifications for mouse and cat (Additional file 2: Table S3) and called peaks using the
same methods as for other replicates (ChIP-seq peak calling and signal saturation (Fig-
ures S1, S2A and S2B)). We then used all possible combinations of three replicates to
estimate interindividual reproducibility (Definitions of regulatory regions (Fig. 1c and
Table S4)) as a measure of both the variation between individuals and biases introduced
by our analyses.





PIk, l—fraction of active promoters with regulatory activity between a pair of bio-
logical replicates k and l, i.e. reproducible between individuals
PIk→ l —number of active promoters in individual k that overlap a regulatory active
region in individuallby at least one base
PAk —total number of active promoters in individual k
Figure 3b and c show PMi, j (Eq. 3) for every pair of species at divergence > 0 MYA
(45 comparisons) and PIk, l (Eq. 4) at divergence = 0 for every pair of 4 mouse and every
pair of 4 cat biological replicates (12 comparisons). For Fig. 3b, we first plotted regions
identified as tissue-shared in species i and species j, and then regions identified as
tissue-specific in species i and species j. Similarly, for Fig. 3c, we plotted separately all
tissue-specific regions depending on which tissue they were active in. We plotted the
resulting graphs in R version 3.6.2 [91] using ggplot2 version 3.1.1 [92] and performed
linear regression using the geom_smooth() ggplot2 method. To test for statistical sig-
nificance, we fitted the data to a linear model using the R function lm() and tested the
resulting linear models using the built-in anova() function for the interaction of diver-
gence time and tissue-specificity. Specifically, for Fig. 3b, we report the two-way
ANOVA p value for the interaction of divergence time (factor 1) and regions identified
as active promoters and active enhancers (factor 2), for the interaction of divergence
time (factor 1) and regions identified as active promoters and primed enhancers (factor
2), and for the interaction of divergence time (factor 1) and regions identified as active
enhancers and primed enhancers (factor 2). For Fig. 3c, we first report the two-way
ANOVA p value for the interaction of divergence time (factor 1) and active promoters
identified as testis-specific or any other tissue-specific region (factor 2). We then report
the two-way ANOVA p value for the interaction of divergence time (factor 1) and
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active promoters being identified as tissue-specific or tissue-shared (factor 2). All diver-
gence times between species were taken from Ensembl Compara version 98 [90].
Intra-species dynamic regulatory signatures (Fig. 4a and Figure S5)
To define regulatory regions that change regulatory identity between the tissues of a
species, we performed cross-tissue overlap as described for determining tissue-specific
and tissue-shared regions (Intra-species cross-tissue activity (Fig. 2a, Figures S5 and
S6A)). Briefly, if regulatory regions of different identities overlapped each other with at
least 50% of their length between tissues, we called these regions intra-species dynamic
(Additional file 1: Figure S5). Specifically, overlap of an active promoter in one tissue to
either an active or primed enhancer in another tissue was called a dynamic promoter/
enhancer (dynamic P/E), while the overlap of an active enhancer in one tissue to a
primed enhancer in another tissue was called a dynamic enhancer (dynamic E). The
sum of all dynamic regions, and non-dynamic regions, across all ten species is shown
in Fig. 4a.
Evolutionary dynamic regulatory signatures (Fig. 4b and Figure S5)
For all maintained regulatory regions (PMi, j Eq. 3, The recently evolved and maintained
regulomes across species (Fig. 3a), Additional file 1: Figure S5), we next asked how the
regulatory signature changes through evolution. For each pairwise comparison between
species, we counted how many regulatory regions of one identity aligned with at least
one base to a regulatory region of all other signatures. These calculations were limited
only to maintained regulatory regions which only align to one other regulatory region
between species. The text below shows the calculation for active promoters as an ex-
ample, but all other regulatory regions were calculated similarly.
NPMi→ j ¼ PPi→ j þ PAEi→ j þ PPEi→ j þ PDPi→ j þ PDEi→ j ð5Þ
NPMi→ j—total number of maintained promoters in species i when compared to spe-
cies j
PPi→ j—Total number of active promoters in species i with a 1-to-1 alignment to at
least one base of an active promoter in species j; these represent evolutionarily stable
promoter signatures
PAEi→ j—Total number of active promoters in species i with a 1-to-1 alignment to at
least one base of an active enhancer in species j; these represent evolutionarily dynamic
promoter signatures
PPEi→ j—Total number of active promoters in species i with a 1-to-1 alignment to at
least one base of a primed enhancer in species j; these represent evolutionarily dynamic
promoter signatures
PDPi→ j—Total number of active promoters in species i with a 1-to-1 alignment to at
least one base of an intra-species dynamic promoter region in species j; see also the
Intra-species dynamic regulatory signatures (Figs. 4a and S5) section
PDEi→ j—Total number of active promoters in species i with a 1-to-1 alignment to at
least one base of an intra-species dynamic enhancer region in species j; see also the
Intra-species dynamic regulatory signatures (Figs. 4a and S5) section
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Figure 4b shows the ∑(PPi→ j + PAEi→ j + PPEi→ j + PDPi→ j + PDEi→ j) for all pairs of
species for the active promoters, and analogous calculations for the other regulatory re-
gions, in a Circos plot [93]
Evolutionary dynamic regulatory identities across divergence time (Fig. 4c)
Next, we asked if evolutionary dynamics of promoter and enhancer signatures is corre-
lated to the divergence time between species. For this, we focused on all maintained
regulatory regions (The recently evolved and maintained regulomes across species (Fig.
3a)) between pairs of species and asked how often they align to a regulatory region with
another regulatory signature (Evolutionary dynamic regulatory signatures (Fig. 4b and
Figure S5)). The comparisons were limited to 1-to-1 aligned regulatory regions.





PWi, j—fraction of maintained active promoters switching regulatory activity between
species i and j, i.e., aligned to a regulatory active region, defined as evolutionarily dy-
namic promoter signatures. See also Eq. 5
PWi→ j—number of active promoters in species i aligned to an active or primed en-
hancer in species j
PMi→ j—number of active promoters in species i aligned to any regulatory region in
species j; see also Eq. 3
PWj→ i—number of active promoters in species j aligned to an active or primed en-
hancer in species i
PMj→ i—number of active promoters in species j aligned to any regulatory region in
species i; see also Eq. 3
AEWi; j ¼ AEWi→ jAEMi→ j
 
 100 ð6:1Þ
AAEWi, j—fraction of maintained active enhancers switching regulatory activity be-
tween species i and j, i.e., aligned to a regulatory active region, defined as evolutionarily
dynamic enhancer signatures. See also Eq. 5
AEWi→ j—number of active enhancers in species i aligned to a primed enhancer in
species j
AEMi→ j—number of active enhancers in species i aligned to any regulatory region in
species j; see also Eq. 3
Figure 4c shows the PW, j and AEWi, j between all pairs of species (45 comparisons) for
every pair of species at divergence > 0 MYA (45 comparisons) and at divergence = 0 the
average intra-species dynamic activity (Intra-species dynamic regulatory signatures (Figs.
4a and S5)). All divergence times between species were taken from Ensembl version 98
[90]. We plotted the resulting graphs in R version 3.6.2 [91] using ggplot2 version 3.1.1
[92] and performed linear regression using the geom_smooth() ggplot2 method
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Outgroup analysis (Fig. 4d, Figures S8B and S8C)
Whole genome alignments of regulatory regions were parsed to get all 1-to-1 alignments
for mouse/rat/rabbit and separately for cat/dog/horse (see the Evolutionary dynamic regu-
latory signatures (Fig. 4b and Figure S5) section). Only genomic regions that were main-
tained as either an active promoter, active enhancer, or primed enhancer in all three of
the species in the triad (mouse/rat/rabbit and cat/dog/horse) were considered in this ana-
lysis. Genomic regions identified as an intra-species dynamic region in any of the three
species were excluded from this analysis for simplicity. Analyses were done separately for
each triad. The overall proportion of active promoters, active enhancers, and primed en-
hancers in the outgroup species (rabbit or horse) for the genomic regions considered is
shown as “All” in Fig. 4d and Additional file 1: Figure S8. Given the combination of regu-
latory signatures in the ingroup species (mouse/rat or cat/dog), we asked what the identity
was in the outgroup species (rabbit or horse, respectively). For example, in the AP/AE
situation, this could represent either an active promoter in mouse and an active enhancer,
or vice versa. The regulatory signature of the genomic region in rabbit would then be
queried. Percentages and raw numbers are shown separately for each triad in Additional
file 1: Figure S8B and Additional file 1: Figure S8C. The combined numbers and percent-
ages are also shown in the bottom panels of Additional file 1: Figure S8B and C and in
Fig. 4d. Chi-square two-tailed tests (degrees of freedom = 2) were used to test whether
outgroup distributions of active promoters, active enhancers, and primed enhancers for
each ingroup combination differed statistically from the background (“All”) distribution
(Fig. 4d). Expected values were calculated based on the percentages of active promoters,
active enhancers, and primed enhancers in the background.
Model of evolutionary dynamics between regulatory regions (Fig. 4e)
For the model of all possible evolutionary dynamics between active promoters (AP), active
enhancers (AE) and primed enhancers (PE), we extracted probabilities using the observed
frequencies in the triad analysis above (Outgroup analysis (Fig. 4d, Figures S8B and C)).
For each regulatory region, we calculated the relative probabilities of retaining the same
signature (AP→AP, AE→AE, and PE→ PE), and changing to a regulatory region of an-
other signature (for example, AP→AE or AE→AP). The probabilities were calculated
from the observed frequencies in both outgroup analyses combined (mouse/rat/rabbit
and cat/dog/horse), using only those evolutionary relationships where parsimony could be
used to determine the ancestral state as a single regulatory region signature.
Specifically, for active promoters:





P AP→APð Þ þ P AP→AEð Þ þ P AP→PEð Þ ð7:1Þ
P(AP→AP)—probability of an ancestral active promoter remaining an active pro-
moter. Observed frequency from triad relationship ingroups AP/AP and outgroup AP
P(AP→AE)—probability of an ancestral active promoter evolving to an active enhan-
cer. Observed frequency from triad relationship ingroups AP/AE and outgroup AP
P(AP→ PE)—probability of an ancestral active promoter evolving to a primed enhan-
cer. Observed frequency from triad relationship ingroups AP/PE and outgroup AP
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Specifically, for active enhancers:





P AE→AEð Þ þ P AE→APð Þ þ P AE→PEð Þ ð8:1Þ
P(AE→AE)—probability of an ancestral active enhancer remaining an active enhan-
cer. Observed frequency from triad relationship ingroups AE/AE and outgroup AE
P(AE→AP)—probability of an ancestral active enhancer evolving to an active pro-
moter. Observed frequency from triad relationship ingroups AE/AP and outgroup AE
P(AE→ PE)—probability of an ancestral active enhancer evolving to a primed enhan-
cer. Observed frequency from triad relationship ingroups AE/PE and outgroup AE
Specifically, for primed enhancers:





P PE→PEð Þ þ P PE→APð Þ þ P PE→AEð Þ ð9:1Þ
P(PE→ PE)—probability of an ancestral primed enhancer remaining a primed enhan-
cer. Observed frequency from triad relationship ingroups PE/PE and outgroup PE
P(PE→AP)—probability of an ancestral primed enhancer evolving to an active pro-
moter. Observed frequency from triad relationship ingroups PE/AP and outgroup PE
P(PE→AE)—probability of an ancestral primed enhancer evolving to an active en-
hancer. Observed frequency from triad relationship ingroups PE/AE and outgroup PE
Figure 4e shows the resulting calculations for all evolutionary relationships as num-
bers above the arrows.
ChIP-seq and RNA-seq read enrichment around evolutionarily dynamic regulatory
regions (Figs. 4f and g)
To validate evolutionary switching from active enhancer to active promoter (evolution-
ary dynamic P/Es, Additional file 1: Figure S5), we selected a subset of regulatory re-
gions from the outgroup analysis (Outgroup analysis (Fig. 4d, Figures S8B and S8C))
that are most likely to represent a true evolutionary switch. Specifically, we only chose
those regions that had an active promoter signature in one ingroup, an active enhancer
signature in the other ingroup, and an active enhancer signature in the outgroup as the
most parsimonious conclusion is that the ancestral state was an active enhancer.
For Fig. 4f, we separated these regions within each outgroup species into sets that
showed active promoter signature (“AP Dynamic”) and active enhancer signature (“AE
Dynamic”). We then selected from the same species the same number of control re-
gions as those that never show evolutionarily dynamic activity. We next generated the
per-species averages of ChIP-seq enrichment across these regions for all replicates of a
species as described before (Enrichment of called regulatory regions (Figures S2C, S4
and S8)) but extending the flanking regions to 10 Kb. Finally, we averaged across all
per-species averages to generate the graphs in Fig. 4f.
For Fig. 4g, we used the same AP Dynamic and AE Dynamic sets as described above,
but only the active enhancers as control regions. For RNA-seq enrichment plots, we
used local installations of deepTools version 3.3.1 [85] and WiggleTools mean [86] to
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calculate the maximum RNA-seq enrichment across all biological replicates across all
tissues in a species. For Fig. 4g, the resulting maximum RNA-seq values were compared
between evolutionarily dynamic and control regions using the deepTools computeMa-
trix program with the options scale-regions --beforeRegionStartLength 10000 --afterRe-
gionStartLength 10000 --missingDataAsZero --regionBodyLength 2000 –skipZeros
within each species. To generate the resulting boxplots in Fig. 4g, all species’ values
were combined. The p values were calculated with the ggpubr package in R [94], using
the stat_compare_means function using a t test testing if active promoters (AP) had
higher expression than active enhancers (AE) than control regions.
Tissue-specificity of evolutionarily dynamic regions (Fig. 4h)
To create the tissue-specificity UpSetR version 1.4.0 plots [88] in Fig. 4h, we extracted
all regions corresponding to evolutionary dynamic promoter signatures (Additional file
1: Figure S5, Evolutionary dynamic regulatory signatures (Fig. 4b and Figure S5)). Spe-
cifically, we extracted those active promoters that have a 1-to-1 alignment to an active
or primed enhancer in any other species and active and primed enhancers that have a
1-to-1 alignment to an active promoter in another species. We then considered the
tissue-specificity of the regions categorizing them according to the regulatory identity
in the species they were extracted from. For example, for a region identified as an active
promoter in rat and an active enhancer in rabbit, we considered its tissue-specificity
only in rat for the active promoter category and tissue-specificity only in rabbit for the
active enhancer category. We plotted the within species tissues specificity of those se-
lected regulatory regions as outlined in the “Materials and methods” section Intra-
species cross-tissue activity (Fig. 2a, Figures S5 and S6A). We performed all statistical
tests using the binom.test() function in R version 3.6.2 [91].
Repeat masking and classification of transposable elements
To identify transposable elements in all genomes, we used RepeatMasker version open-
4.0.7 [95] using the crossmatch search engine and RepBase Release 20,170,127 [96]. For
each species we ran RepeatMasker in the default mode, specifying the species’ scientific
name (macaque, “Macaca mulatta”; narmoset, “Callithrix jacchus”; mouse, “Mus mus-
culus”; rat, “Rattus norvegicus”; rabbit, “Oryctolagus cuniculus”; pig, “Sus scrofa”; dog,
“Canis familiaris”; cat, “Felis catus”; horse, “Equus caballus”; opossum, “Monodelphis
domestica”). For figures, we used DNA, LINE, LTR, and SINE categories from RepBase
annotation. These correspond to different levels of transposable element classification
hierarchies [23], but still represent exclusive non-overlapping sets of the hierarchy.
Namely, DNA corresponds to the DNA transposons class, while all other groups belong
to the retrotransposon classes. The LTRs are a subclass of retrotransposons, while the
LINEs and SINEs are superfamilies of the non-LTR subclass of retrotransposons.
Relative transposable element enrichment of tissue-specific and tissue-shared recently
evolved regulatory and maintained regions (Fig. 5a and Figure S9B, Tables S6 and S7)
We first extracted all recently evolved and maintained regulatory regions (Additional file 1:
Figure S5, The recently evolved and maintained regulomes across species (Fig. 3a)). Next,
within each species, we calculated the number of tissue-specific recently evolved regions that
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overlap half the length of transposable elements within subgroups as defined by RepBase (Re-
peat masking and classification of transposable elements). For example, for tissue-specific ac-
tive promoters overlapping any LINE with at least one base, we counted the number
occurring in all possible subgroups (for example, L1, L2, and CR1). We next repeated the
same process for tissue-shared active promoters overlapping any LINE. To generate the rela-
tive enrichment shown in Fig. 5a and Additional file 1: Figure S9B, we calculated the percent
of tissue-specific and tissue-shared regulatory regions overlapping specific subgroups by div-
iding each subgroup count by the total counts for that group and multiplying by 100. For ex-
ample, for L1, we divided the number of tissue-specific active promoters overlapping an L1
by the total number of tissue-specific active promoters overlapping any LINE. Similarly, for
the tissue-shared, we divided the number of tissue-shared active promoters overlapping an
L1 by the total number of tissue-shared active promoters overlapping any LINE. Finally, we
subtracted the tissue-shared portions with the tissue-specific to generate a relative enrich-
ment. Consequently, positive values indicate a higher proportion of that subgroup in the
tissue-specific than in the tissue-shared. For example, pig has a value of 16 for L1 active pro-
moters because 47% of all tissue-specific active promoters overlapping a LINE belonged to
the L1 subgroup, compared to 31% of the tissue-shared active promoters. The heatmap of all
relative enrichments in Fig. 5a and Additional file 1: Figure S9B were generated using the
heatmap.2() function in gplots package version 3.0.1.1 [97]. The p values were calculated on
the original counts, using the Z-test in R base function prop.test and Bonferonni correction
using the total number of tests across the matrix implemented in R base function p.adjust.
For generating the heatmaps images, we filtered all possible subgroups to include only those
that have at least 100 tissue-specific and 100 tissue-shared occurrences in any species and
manually refined the selection to only include those that are informative for multiple lineages,
but total counts across all subgroups were used for the p value calculations.
Figure 5a shows the relative transposable element enrichments for recently evolved
regulatory regions, while Additional file 1: Figure S9B shows the enrichments for main-
tained regulatory regions.
LINEs in random genomic regions (Figure S9)
To compare LINE overlap of regulatory regions to random regions, within each species, we
randomly selected the same number and length of random regions as there were regulatory
regions using bedtools shuffle and excluding those regions that we found to be regulatorily
active. We then overlapped these random regions with LINEs, requiring 50% overlap with
LINEs, and compared the portion of random and regulatory regions that overlapped a LINE.
ChIP-seq and RNA-seq read enrichment around LINE-associated recently evolved
regulatory regions (Fig. 5b and c)
To examine the raw signal surrounding LINE-associated active promoters, we first ex-
tracted recently evolved active promoters overlapping a LINE L1 or LINE L2 with at
least one base (overlap defined in the “Relative transposable element enrichment of
tissue-specific and tissue-shared recently evolved regulatory and maintained regions
(Fig. 5a and Figure S9B, Tables S6 and S7)” section). We next chose those active pro-
moters that had overlap with LINE L2s and have tissue-shared activity (as defined in
the Intra-species cross-tissue activity (Fig. 2a, Figures S5 and S6A) section). For those
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active promoters that had overlap with LINE L1s and were tissue-specific, we further
subdivided them by the tissue of activity. For Fig. 5b, we generated the per-tissue aver-
ages of ChIP-seq enrichment across all replicates of a species as described before (En-
richment of called regulatory regions (Figures S2C, S4 and S8)) but making an average
across all replicates of a tissue within a species and extending the flanking regions to
10 Kb. Finally, we combined averaged across all per-species averages to generate the
graphs in Fig. 5b.
For RNA-seq enrichment plots, we used local installations of deepTools version 3.3.1
[85] and WiggleTools max [86] to calculate the maximum RNA-seq enrichment across
all biological replicates of the tissue. For Fig. 5c, the resulting maximums RNA-seq
values were compared to LINE associated active promoters using the deepTools com-
puteMatrix program with the options scale-regions --beforeRegionStartLength 10000
--afterRegionStartLength 10000 --missingDataAsZero --regionBodyLength 2000 –skip-
Zeros within each species. To generate the resulting boxplots in Fig. 5c, all species’
values were combined. The p values were calculated with the ggpubr package in R [94],
using the stat_compare_means function using a t-test testing if the mean of each box-
plot is significantly different from all other expressed in that tissue (i.e., within rows).
Age of LINEs (Fig. 5d and Figure S10A)
To estimate the age of LINEs, we used the percent mutations from RepBase consensus se-
quences of each element as reported by RepeatMasker (Repeat masking and classification
of transposable elements). We extracted all LINE L2 and L1 matches in the genome and
characterized them as regulatorily inactive if they did not overlap a regulatory region we
identified in this project, as recently evolved regulatory region if they were recently
evolved (The recently evolved and maintained regulomes across species (Fig. 3a)), and
evolutionarily dynamic regulatory signature if we had found them to align to a regulatory
region of another signature (Evolutionary dynamic regulatory signatures (Fig. 4b and Fig-
ure S5)). For Fig. 5d, we plotted the mutations for all species combined, while Additional
file 1: Figure S10A shows the same data but split by the species it was identified in. The p
values were calculated with the ggpubr package in R [94], using the stat_compare_means
function and a one-sided Wilcoxon test between all pairs of categories (regulatorily in-
active, recently evolved, and evolutionarily dynamic regulatory region).
Relative transposable element enrichment of evolutionarily dynamic and stable
regulatory signatures (Fig. 5e)
We first extracted all evolutionarily dynamic regulatory regions, i.e., evolutionarily dy-
namic promoters and evolutionarily dynamic enhancers (Evolutionary dynamic regula-
tory signatures (Fig. 4B and Figure S5)). To calculate the relative enrichment of
evolutionarily dynamic regions (switch regulatory regions) to those not found to be
evolutionarily dynamic (stable regulatory regions), we performed calculations similar to
the recently evolved relative enrichment (Relative transposable element enrichment of
tissue-specific and tissue-shared recently evolved regulatory and maintained regions
(Fig. 5a and Figure S9B, Tables S6 and S7)) but changing the groups of regulatory re-
gions being compared. To generate the relative enrichment shown in Fig. 5e, for each
category of regulatory region, we subtracted the percentage of stable regulatory regions
Roller et al. Genome Biology           (2021) 22:62 Page 37 of 43
belonging to a subgroup from the percentage of evolutionarily dynamic regulatory re-
gions. Consequently, positive values indicate a higher proportion of that subgroup in
the evolutionarily dynamic than in stable regulatory regions. For example, rat has a
value of − 11 for L1 active enhancers because 63% of all evolutionarily dynamic active
enhancers overlapping a LINE belonged to the L1 subgroup, compared to 74% of the
stable active enhancers. The heatmap of all relative enrichments in Fig. 5e was gener-
ated using the heatmap.2() function in gplots package version 3.0.1.1 [97]. The p values
were calculated on the original counts, using the Z-test in R base function prop.test
and Bonferroni correction using the total number of tests across the matrix imple-
mented in R base function p.adjust. For generating the heatmaps images, we filtered all
possible subgroups to include only those that have at least 100 tissue-specific and 100
tissue-shared occurrences in any species and manually refined the selection to only in-
clude those that are informative for multiple lineages, but total counts across all sub-
groups were used for the p value calculations.
Multimapping and unique reads (Additional file 7: Table S8)
To compare the proportion of reads mapping uniquely in the non-repetitive genome
and within LINEs, we found all multimapping reads in three genomic categories. For
the non-repetitive genome, we found all reads that were not masked by RepeatMasker
as simple repeats or transposable elements (Repeat masking and classification of trans-
posable elements). Next, we found all reads overlapping LINE L1s and LINE L2 frag-
ments as determined by overlap with RepeatMasker annotations. We counted those
duplicate removed reads that were marked by bwa with the “XA:Z” flag as unique
(ChIP-seq mapping (Figures S1 and S2)).
Constrained element content in tissue-specific LINEs (Figures S10D and E)
To examine the difference in sequence constraint within regulatorily active LINE transposable
elements and avoid bias, we focused on those LINE elements that overlapped tissue-specific
regulatory regions in all species. For Additional file 1: Figure S10D for each tissue-specific
regulatory region associated with a LINE L1 or L2, we extracted the GERP rejected substation
scores [98] from Ensembl version 98 [90]. Briefly, unalignable genomic regions do not have a
GERP score, while a negative score in alignable indicates more sequence constraint than ex-
pected and a positive score indicates less. We plotted the resulting graphs in R version 3.6.2
[91] using ggplot2 version 3.1.1 [92] and calculated p values using the base R wilcox.test.
For Additional file 1: Figure S10E, we extracted the number of constrained elements,
i.e., short genomic regions that have more sequence constraint than expected [98], for
each tissue-specific regulatory region associated with a LINE L1 or L2 from Ensembl
version 98 [90]. Unlike the analysis reported in Fig. 5c, this includes also unalignable
genomic regions. We plotted the resulting graphs in R version 3.6.2 [91] using ggplot2
version 3.1.1 [92] and calculated p values using the base R chisq.test.
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